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Abstract
The Golgi apparatus is organised as a ‘ribbon’ o f interconnected stacks of membranous 
cistemae that have characteristic enzyme compositions that define where cargo proteins are 
glycosylated during their transport towards the plasma membrane in mammalian cells. 
There are two classes of Golgi transport schemes: one based on stable cistemae, and the 
other on ‘maturing’ cistemae. With the stable cistemae model, the Golgi resident proteins 
(e.g., glycosylating enzymes) always remain in the same cistema and the secretory cargo is 
transported forwards in vesicles, to move progressively from one cistema to the next. 
According to the maturation scheme, new cistemae form at the cA-Golgi face, and then 
‘move forward’ through the stack; at the same time, the cistemae ‘mature’ by acquiring, 
and then losing, the glycosylating enzymes, which recycle backwards in step with cargo 
progression. Here, the cargo remains stable within the cistema, and is transported forwards 
within the advancing cistemae. While the maturation mechanism has significant 
experimental support, the cmcial evidence that Golgi enzymes recycle through the stack in 
mammalian cells remains missing. In the present study, I designed experiments based on 
the use of Golgi-resident enzyme constructs that can be reversibly polymerised to 
distinguish the maturing versus stable cistemae models. The data strongly fit with the 
predictions of the cisternal maturation model.
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CHAPTER 1
Introduction
1.1 From the cis to the trans face of the Golgi apparatus: structure and 
function
More than a century ago, the anatomist Camillo Golgi discovered a new organelle using 
the “black reaction” in neuronal cells, which causes the deposition of silver on histological 
sections. Initially defined as “apparato reticolare intemo” (Golgi 1989), the Golgi 
apparatus was first considered to be an artefact o f fixation, and only with the introduction 
of electron microscopy (EM) into the field of biology was it possible to establish the 
structure and the preserved nature of the Golgi apparatus as an organelle that is conserved 
in almost all cell types (Farquhar and Rinehart 1954; Sjostrand and Hanzon 1954; Dalton 
and Felix 1954).
In mammalian cells, the Golgi apparatus is composed o f 70-100 Golgi stacks that 
are connected to each other by networks of tubules, called the non-compact zones, that 
form a ribbon-like structure that localises in the peri-nuclear region of the cell, near to the 
microtubule organising centre (MTOC). Each Golgi stack can be divided into three 
morphologically and functionally different regions, called the cis-, medial- and trans-Golgi, 
where specific Golgi resident proteins are located that provide the identity o f each o f these 
compartments (Dunphy and Rothman 1985; Mellman and Simons 1992). Every stack 
intercalates between two networks of membranes that represent the entrance face of the 
Golgi, named the c/s-Golgi network (CGN), and the exit face of the Golgi, named the 
trans-Golgi network (TGN). The flux of membranes and proteins that reach and leave the 
Golgi apparatus must be accurately tuned to maintain the homeostasis and the correct
14
function of the Golgi (Wieland, Gleason et al. 1987), and both the CGN and the TGN have 
important roles in this process.
1.1.1 Endoplasmic reticulum exit sites
Proteins that follow the secretory pathway are first synthesised by the endoplasmic 
reticulum (ER)-associated ribosomes, and then can be co-translationally inserted into the 
ER membranes. Alternatively, the proteins can be post-translationally translocated across 
the ER membrane and, after folding, they usually concentrate at the level of the ER exit 
sites (ERES). These are ribosome-free portions o f the ER membranes that form O-shape 
profiles or ‘buds’ when seen by EM; these are coated with the COPII coatomer (see Fig. 
1.1; Palade 1975; Sesso, de Faria et al. 1994; Bannykh, Rowe et al. 1996). The budding 
process at the ERES starts when Sec 12 activates the Sari GTPase through the exchange of 
GDP for GTP. Sarl-GTP induces deformation of the ER membrane by insertion of a 
hydrophobic N-terminal helix into the membrane bilayer. Sarl-GTP then drives the initial 
recruitment of Sec23-24, a heterodimer that represents the inner layer of the COPII coat, in 
contact with the forming vesicle membrane. Subsequently, a second heterodimer, 
composed of Secl3-31, which represents the outer layer of the COPII coat, recognizes the 
premature complex composed of Sarl-GTP, Sec23-24, and the cargo. This interaction 
supports membrane bending, leading finally to vesicle formation and fission from the ER 
membrane (Barlowe, Orci et al. 1994; Barlowe 2003). The newly generated COPII-coated 
carriers then lose their coat, and can homotypically fuse with each other or with the 
network of membranes known as vesicular-tubular clusters (VTCs) (Bannykh, Rowe et al. 
1996).
15
1.1.2 Vesicular-tubular clusters
The VTCs are also known as the ER-Golgi intermediate compartment (ERGIC) (Hauri, 
Kappeler et al. 2000), and this represents the cross-roads of the early secretory pathway for 
the exchange of membranes with the ER from one side and with the Golgi apparatus on the 
other. From a morphological point of view, the VTCs appear as a network of membranes 
that is composed o f vesicles and/or tubules that, when branched, appear with a typical 
triangular shape (see Fig. 1.1). Rarely, the ER can be connected with the VTCs (Bannykh, 
Nishimura et al. 1998), but frequently tubules that connect the VTCs with the first cis- 
Golgi cistema can be seen (Krijnse-Locker, Ericsson et al. 1994). The main function of the 
VTCs is to allow the recycling of ER components, like chaperones, cargo receptors, and 
other ER-resident proteins, so that they can return to the ER to start a new cycle of  
transport (Breuza, Halbeisen et al. 2004). This function is mediated by a heptameric 
protein complex that constitutes a different coatomer, called COPI (Lewis and Pelham 
1990; Letoumeur, Gaynor et al. 1994). Additional functions o f the VTCs include 
glycosylation (Krijnse-Locker, Ericsson et al. 1994), concentration of cargo proteins that 
have to proceed through the secretory pathway (Martinez-Menarguez, Geuze et al. 1999), 
and an additional control of protein folding (Zuber, Fan et al. 2001; Anelli, Ceppi et al. 
2007). The most specific marker of the VTCs is the protein ERGIC53, which shows a tight 
segregation between VTCs and the Golgi membranes (see review by Klumperman 2011).
How the cargo reaches the Golgi apparatus is still under debate (reviewed in 
(Polishchuk and Mironov 2004). From the one hand, it is proposed that VTC-derived 
carriers fuse with a pre-existing c/s-Golgi cistema. This concept implies that there is a 
specific subset of COPI-coated carriers that contain anterograde cargoes to transport them 
to the czs-Golgi. On the other hand, VTCs can be seen as anterograde carriers in their own 
right. According to this model, VTCs can fuse with each other to generate a cA-Golgi 
cistema that will then mature, to allow cargo transport from the cis- to the trans-Golgi sub- 
regions.
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1.1.3 The Golgi stack
The Golgi stack represents the basic structural unit of the mammalian Golgi ribbon. The 
Golgi ribbon is composed of about 100 stacks that are laterally connected to each other 
through a network of tubules and vesicles that extends for a length that can vary from 200 
nm to 800 nm, known as the non-compact zone (Thome-Tjomsland, Dumontier et al. 1998; 
Ladinsky, Mastronarde et al. 1999). Morphologically, each Golgi stack appears as a series 
of cistemae that vary from 3 to 11 in number, and range from 0.7 pm to 1.1 pm in length 
(Rabouille, Misteli et al. 1995). These are juxtaposed and aligned, and they are held 
together by the Golgi matrix proteins (see Fig. 1.1) (Franke, Kartenbeck et al. 1972; Cluett 
and Brown 1992; Slusarewicz, Nilsson et al. 1994; Sinka, Gillingham et al. 2008; Ramirez 
and Lowe 2009). The cistemae are typically tight in the central part (10-20 nm) and dilated 
at the periphery; moreover, they have holes of varied diameters from <65 nm to up to 100 
nm. There are called perforated zones, and they decrease in number and size going from 
the cis- to medial Golgi, and increase again along the medial to trans axis (Ladinsky, 
Mastronarde et al. 1999). The cis- and /raws-sides of the Golgi stacks share similar 
morphological characteristics, like the presence of fenestrae, and small round profiles and 
tubules that are projected into the cytosol to form a network of interconnected membranes.
Another important characteristic of the Golgi stack is the presence o f COPI-coated 
vesicles that under EM appear as round electron-dense profiles of 50 nm to 80 nm in 
diameter, and are present within a 200-nm distance from the rims of the cistemae. Rarely, 
tubules connecting heterologous cistemae can be seen, which have the same diameter as a 
normal cistema (20 nm). In certain specific cell types, these tubules can increase in number, 
which probably reflects an increase in the cell secretory needs (Vivero-Salmeron, Ballesta 
et al. 2008). It is also known that intercistemal connections can form during the arrival of 
cargo at the Golgi apparatus, a process in which cytosolic phospholipase (PLA) 2  has a key 
role (San Pietro, Capestrano et al. 2009). Whether vesicles and tubules represent a shuttle
17
for the anterograde cis to trans movement of proteins in the Golgi apparatus or whether 
they have a role in the recycling of the Golgi enzymes is still under debate.
Glycosylation is the main, but not the only, function of the Golgi apparatus 
(Mellman and Simons 1992; Rabouille, Misteli et al. 1995; Varki 1998). Indeed, the Golgi 
apparatus is also a signalling platform that participates in the partitioning and integration of  
many signalling molecules, in addition to being a site for lipid biosynthesis including many 
sphingolipids (van Meer 1998). At the ultrastructural level, ER membranes that do not 
have ribosomes (i.e., smooth ER) can be found in tight contact (<10 nm) with the trans- 
cistema o f the Golgi stack, which forms a region defined as “ER-Golgi membrane contact 
sites”, which have a key role in the regulation of the amount and homeostasis of the 
sphingolipids (Ladinsky, Wu et al. 2002).
1.1.4 The trans-Golgi network
The TGN is the main interchange station of the endocytic and exocytic pathways, and it 
represents a platform where proteins and lipids coming from the Golgi apparatus are sorted 
to their final destination (see review by De Matteis and Luini 2008). Structurally, the TGN 
appears as a network of membranes that is composed of tubules, vesicles and pleiomorphic 
carriers that can vary in size and shape (see Fig. 1.1) between cell types and depending on 
the level of protein synthesis (Hand and Oliver 1984; Griffiths, Fuller et al. 1989).
Besides the presence of COPI coated buds, a peculiar feature of the TGN is the 
presence o f a different coat protein, named clathrin (see Fig. 1.1), which gives an identity 
to this compartment and provides functional discrimination from the other Golgi cistemae 
(Pearse and Robinson 1990). The diameter o f clathrin-coated membrane buds is about 100 
nm (Peden, Oorschot et al. 2004) and a typical spiky pattern can also be revealed on TGN 
tubules (Ladinsky, Wu et al. 2002, Mogelsvang, Marsh et al. 2004). However, not all post- 
Golgi carriers show this coat or a regular shape, as in the case o f large pleiomorphic
18
carriers containing vesicular stomatitis virus glycoprotein (VSVG) (Polishchuk, 
Polishchuk et al. 2000).
The trans-most cistema of each Golgi stack also appears to be part of the TGN 
(Clermont, Rambourg et al. 1995; Griffiths, Pfeiffer et al. 1985). This consideration is, 
however, in contrast to many observations that have highlighted the different identity of 
the TGN, which is considered to be an independent organelle (Geuze and Morre 1991). For 
example, the composition of membrane lipids, proteins and enzymes is different 
comparing Golgi stacks and the TGN (Novikoff 1976); Moreover, the pH of the TGN is 
particularly low, and more similar to that of the late endosomal compartment. In agreement 
with these experimental observations, the use of brefeldin A (BFA), an inhibitor of Arfl 
(Fujiwara, Oda et al. 1988), induces the fusion of the Golgi apparatus with the ER, while 
the TGN appears to mix with the recycling endosomal system (Lippincott-Schwartz, Yuan 
et al. 1991).
19
Figure 1.1 Electron microscopy micrograph depicting the secretory pathway.
HeLa cells were plated, and after 24 h they were fixed and processed for regular EPON 
embedding (see Materials and Methods, Electron microscopy tomography, section 3.16). 
After sample embedding, thin sections (60-70 nm) were obtained and examined under EM 
(Tecnai-12; FEI). Each compartment of the secretory pathway is indicated. See text for 
abbreviations. Bar: 150 nm.
20
1.2 Intracellular membrane-transport regulators
One of the main classes of molecular regulators of intracellular membrane transport is the 
superfamily of small GTP-binding proteins that includes the Ypt/Rab, Arf and Rho 
families. These molecules can switch between an active membrane-associated GTP-bound 
state to a cytosolic inactive GDP-bound state. This reversible GDP-GTP switching is 
regulated by two family of proteins - guanine nucleotide-exchange factors (GEFs) catalyse 
the replacement of GDP with GTP, whereas GTPase activating proteins (GAPs) trigger 
GTP hydrolysis to GDP (Bos, Rehmann et al. 2007).
The Arf proteins can be grouped into three classes: the Golgi-localised Class I 
(Arfl, 2 and 3) and II (Arf4 and 5) proteins, and the class III protein that includes only 
Arf6, which has a role at the plasma membrane (PM). One o f the best characterised Arfs, 
Arfl, has been implicated in the biogenesis o f COPI vesicles. Indeed, soon after the 
activation of Arfl by nucleotide exchange, Arfl-GTP recruits the coatomer onto the Golgi 
membrane (Donaldson, Cassel et al. 1992; Serafim, Orci et al. 1991). Then, Arfl GAPs 
(ArfGAPs) catalyse the GTP hydrolysis (Tanigawa, Orci et al. 1993), thus promoting the 
uncoating o f COPI carriers, which are then free to fuse with their target membrane.
The Rab proteins share a similar structure, with the exception of the hypervariable 
C-terminal region that appears to be an important determinant for Rab localisation 
(Stenmark, Valencia et al. 1994; Ali, Wasmeier et al. 2004). Each step of the intracellular 
transport process requires specific Rab proteins (Bonifacino and Glick 2004). Within the 
Golgi, Rabl and Rab43 have been suggested to promote anterograde transport (see reviews 
by Barr 2009, Dejgaard, Murshid et al. 2008), while Rab6 and Rab33b have been shown to 
be crucial for retrograde transport within the Golgi apparatus and from the Golgi to the ER 
(Martinez, Schmidt et al. 1994; White, Johannes et al. 1999; Valsdottir, Hashimoto et al. 
2001; Jiang and Storrie 2005; Starr, Sun et al. 2010). The Rab proteins can also bind many 
Golgi matrix proteins, including GM130, pi 15, golgin-84, golgin-45, golgin-245 and
21

golgin-97, and these interactions can allow the formation of a tentacular matrix that 
surrounds the Golgi apparatus to capture Rab-coated membranes, which thus contributes to 
the coordination of the intra-Golgi transport process (Munro 2011).
Another class of key molecules involved in the regulation of membrane transport 
within the cell is represented by the soluble N-ethylmaleimide-sensitive factor (NSF) 
attachment protein receptor (SNARE) family of proteins. The SNAREs have roles in the 
final docking and fusion events between transport intermediates and their respective target 
compartment (Sollner, Bennett et al. 1993; McNew, Parlati et al. 2000). Different SNAREs 
have been found in distinct compartments along the secretory and endocytic pathways 
(Jahn and Scheller 2006; Malsam, Kreye et al. 2008). From a functional and topological 
point of view, the SNAREs, which are associated with the vesicle/carrier intermediate, are 
classified as v-SNAREs, and t-SNAREs, which are associated with the cognate target 
compartment. The formation of a trans-SNARE complex, as a result of v-SNARE and t- 
SNARE interactions, catalyses the fusion o f the two opposite membranes in a zipper-like 
fashion (Melia, Weber et al. 2002; Pobbati, Stein et al. 2006). The new c/s-SNARE 
complex is formed in the target compartment and will then be disassembled by the 
combined actions of a-soluble NSF attachment proteins (a-SNAPs) and NSF (Block, Glick 
et al. 1988; Whiteheart, Griff et al. 1993). NSF is an ATPase that functions as an hexamer 
and uses the energy released by the hydrolysis of ATP to dissociate the SNARE complex, 
which liberates the SNAREs for a new cycle of docking and fusion events (Sollner, 
Whiteheart et al. 1993; Mayer, Wickner et al. 1996).
Concerning the vesicles that provide transport within the Golgi apparatus, there are 
two SNARE complexes that have been well characterised and implicated in this process: 
the syntaxin5-Betl-Sec22-membrin complex, and syntaxin5-GS15-GOS28-Ykt6 complex. 
While the t-SNAREs syntaxin5 and GOS28 are homogeneously distributed in the Golgi, 
the v-SNARE Betl, the t-SNAREs Sec22 and membrin show c/s-Golgi concentration,
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compared to the v-SNARE GS15, which shows a more trans-Golgi distribution. The 
differential intra-Golgi compartmentalisation o f these SNAREs might be responsible for 
the vesicle targeting specificity within the Golgi (Volchuk, Ravazzola et al. 2004).
1.3 Mechanisms of localisation of Golgi resident enzymes within the Golgi 
stack
Within the cell there is a huge flux of membranes along the secretory pathway. However, 
despite the enormous amounts of protein and lipid that cross the Golgi apparatus, the 
overall ultrastructural shape and polarity o f the Golgi remains unaffected. At the EM level, 
the cA-Golgi cistemae usually appear fenestrated, whereas the trans-side of the Golgi can 
be morphologically identified by the presence of clathrin-coated vesicles. The sub- 
compartmentalisation of the stack into cis, medial and trans is not only a classification 
based on the morphological features o f the Golgi cistemae, but also a functional 
classification based on the localisation of the Golgi enzymes. There are more than 200 
glycosyltransferases localised to the Golgi, and their localisation within the Golgi stack 
reflects their order of action on their glycolipid and glycoprotein substrates (Mellman and 
Simons 1992; Dunphy and Rothman 1985). For example, a-mannosidase I (MANI) is an 
early acting enzyme that is located at the cis side of the Golgi stack, while a-2,6- 
sialyltransferase is a late-acting enzyme that is enriched at the trans side o f the Golgi stack 
(Komfeld and Komfeld 1985; Roth, Taatjes et al. 1985).
Each enzyme has a gradient distribution across the Golgi stack, with a peak in one 
or two cistemae, which implies that the Golgi residents should contain some characteristics 
that contribute to their specific localisation within the stack. Mutations of regions o f the 
enzymes that are critical for their intra-Golgi localisation, or perturbation o f a machinery 
involved in the retention/recycling process, can strongly impact on the general 
glycosylation process, giving rise to many different diseases (Hu, Eggers et al. 2011; 
Freeze 2013; Reynders, Foulquier et al. 2011).
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Most o f the glycosyltransferases are type II membrane proteins that are composed 
of four domains: a short cytosolic tail, a single transmembrane domain, a stem region, and 
a large luminal catalytic domain. Different mechanisms have been proposed to explain 
how Golgi enzymes are retained/recycled within the Golgi stack, but what is clear is that 
the cytosolic, transmembrane and stem domains are sufficient to localise the residents to a 
particular Golgi subcompartment, possibly through the cooperation of different processes, 
like protein-protein interactions, binding affinity o f the enzymes for COPI, and their 
preference for certain lipid subdomains (Harris and Waters 1996); Todorow, Spang et al. 
2000; Sato, Sato et al. 2001; Abe, Noda et al. 2004; Saint-Jore-Dupas, Gomord et al. 2004; 
Glick and Nakano 2009; Jackson 2009).
1.3.1 The kin-recognition model
The kin-recognition model is based on the observation that different Golgi enzymes can 
homo- or hetero-oligomerise (Nilsson, Hoe et al. 1994; Nilsson, Rabouille et al. 1996) with 
other enzymes that are present in the same compartment (see Fig. 1.3,1). The formation of 
these aggregates not only prevents the complex from entering the budding COPI vesicles, 
but also appears to be important for the correct functioning o f the interacting 
glycosyltransferases (McCormick, Duncan et al. 2000; Giraudo, Daniotti et al. 2001; de 
Graffenried and Bertozzi 2004). For the kin-recognition property o f the enzymes, the 
transmembrane and stem regions o f the glycosyltransferases is known to be essential 
(Weisz, Swift et al. 1993; Nilsson, Rabouille et al. 1996; Opat, Houghton et al. 2000; Qian, 
Chen et al. 2001; Fenteany and Colley 2005).
1.3.2 The bilayer-thickness model
The correlation between the length of the transmembrane domain (TMD) o f a Golgi 
glycosyltransferase and the thickness o f the membrane bilayer (Bretscher and Munro 1993;
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Munro 1998) has led to the postulation of the “bilayer-thickness model”. According to this 
model, the length of the TMD of the Golgi glycosyltransferases is sufficient signal to 
localise these enzymes to a particular lipid bilayer, such that the length of the TMD 
matches with the thickness o f the lipid bilayer (see Fig. 1.3, 2). Different concentrations of 
cholesterol and other sterols are known to influence the thickness of the bilayer. Indeed, in 
the early secretory pathway, where the concentration of these lipids is low, the membrane 
is thinner compared with the PM, which is thicker due to an elevated amount o f sterols (see 
review by Bretscher and Munro 1993). Indeed, a gradient of concentration of cholesterol 
has been shown to be present in the Golgi apparatus, with the TGN being a cholesterol-rich 
compartment compared with the c/s-Golgi (Orci, Montesano et al. 1981). The 
compartmentalisation of the Golgi resident enzymes in sterol-depleted membrane domains 
might then prevent the incorporation of these enzymes into transport vesicles destined for 
the cell surface, providing in this way a mechanism for their retention in the Golgi 
apparatus. An apparent discrepancy does arise however: some enzymes that localise to the 
late-Golgi compartment, like p-l,4-galactosyltransferase (GALT), have a shorter 
transmembrane domain when compared to that of the resident enzymes in the early Golgi 
compartment, like MANI (Becker, Haggarty et al. 2000). This situation can still be 
explained if  the length of the TMD is not the only determinant for the correct localisation 
in certain lipid environments, and thus if  other biophysical properties have important roles 
in this context. The amino acid composition, the shape of the TMD, and the presence of 
positively charged residues in the cytosolic flanking regions of the TMDs can cooperate 
together as a way to reflect the physical properties of the bilayers in which they reside 
(Sharpe, Stevens et al. 2010).
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1.3.3 Golgi glycosyltransferase recycling by the conserved oligomeric 
Golgi complex
A molecular machinery known to have a role in maintaining the correct distribution of the 
Golgi glycosyltransferases within the Golgi cistemae is known as the conserved oligomeric 
Golgi (COG) complex.
The COG complex includes eight subunits that form two lobes: lobe A that includes 
subunits 1-4, and lobe B that is formed by subunits 5-8 (Ungar, Oka et al. 2002). Deletion 
of the lobe A subunits in mammalian cells causes severe glycosylation defects and affects 
cell growth in yeast, whereas a less prominent phenotype appears in both yeast and 
mammals in the absence of the lobe B subunits (Kingsley, Kozarsky et al. 1986; Whyte 
and Munro 2001). The common phenotype for COG complex mutants is alteration of 
glycosylation homeostasis (Miller and Ungar 2012) due to mislocalisation of these Golgi 
resident enzymes (Kingsley, Kozarsky et al. 1986; Oka, Ungar et al. 2004; Zolov and 
Lupashin 2005).
Protein interaction studies have further improved our knowledge at the molecular 
level of the function of the COG complex. Indeed, it is well established that this hetero- 
octameric complex interacts with SNAREs, Rab GTPases, and the COPI coat coatomer 
(Suvorova, Duden et al. 2002, Zolov and Lupashin 2005) to carry out its function. It is also 
known that the COG complex interacts with two golgin proteins, known as p i 15 and 
golgin-84, and in particular, the binding of the COG complex with p i 15 is mediated by the 
Cog2 subunit, a process that has been shown to be essential for maintaining Golgi structure 
(Sohda, Misumi et al. 2007). In the case of golgin-84, this interaction occurs through Cog7, 
and this has been shown to be required for intra-Golgi retrograde transport, through the 
formation of a SNARE complex (Sohda, Misumi et al. 2010).
The role of the COG complex in retrograde transport of vesicles at the Golgi 
apparatus appears to be well accepted (Miller and Ungar 2012). In support o f this, 
depletion of Cog3 led to the accumulation of COG-complex-dependent vesicles that
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contained Golgi glycosyltransferases as cargo (Zolov and Lupashin 2005). Molecular and 
functional experimental details allowed the proposal of a possible model for COG complex 
function in the mechanisms of retention of Golgi glycosyltransferases. In particular, 
through multiple interactions with SNAREs and tethering proteins like golgins and Rab 
GTPases, the COG complex can bind and direct the fusion of COPI vesicles to specific 
sites within the Golgi apparatus, thus promoting the retention of the Golgi resident 
enzymes (see Fig. 1.3,3) through a recycling mechanism (Miller and Ungar 2012).
1.3.4 Golgi glycosyltransferase recycling by VPS74/GOLPH3
A mechanism for the recycling o f glycosyltransferases from the Golgi to the ER and within
the Golgi itself is a well-known process that happens for several glycosyltransferases 
(Harris and Waters 1996; Storrie, White et al. 1998; Todorow, Spang et al. 2000). 
Perturbation of COPI function, or of COPI-interacting proteins like the COG complex 
and/or VPS74/GOLPH3, results in mislocalisation of the Golgi enzymes, which highlights 
the importance of the COPI coat and/or the COPI-related machinery in the context of Golgi 
glycosyltransferase retention (Tu, Tai et al. 2008; Miller and Ungar 2012). Whether COPI 
vesicles and/or tubules (which might be dissociated or connected with adjacent cistemae) 
are involved in this recycling is still under debate (Orci, Amherdt et al. 2000; Lanoix, 
Ouwendijk et al. 2001; Martinez-Menarguez, Prekeris et al. 2001; Kweon, Beznoussenko 
et al. 2004; Trucco, Polishchuk et al. 2004), but recently new evidence came from the 
study o f the molecular mechanisms of COPI-mediated retention o f Golgi 
glycosyltransferases.
VPS74, the yeast homologue of GOLPH3, has been shown to have an essential role 
in the correct localisation of the Golgi enzymes. The dual interactions o f VPS74 with 
COPI and with a conserved sequence (F/L)-(L/V)-(S/T) in the cytosolic tail o f many 
glycosyltransferases is necessary for its function in the localisation o f the Golgi enzymes,
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probably via the recycling of COPI-coated vesicles (see Fig. 1.3, 4). Depletion of VPS74 
results in mislocalisation and degradation of a subset of glycosyltransferases in yeast, 
which includes Mnn2, Mnn9 and Ktr6 CT, and VPS74 overexpression induces a relocation 
of Kre2CT from the Golgi apparatus to the ER. The many similarities between GOLPH3 
and VPS74, including structural ones, suggest that the functions o f GOLPH3 and VPS74 
are likely to have been preserved. Indeed, GOLPH3 and its paralogue GOLPH3L can 
partially substitute for VPS74 when they are expressed in mutant yeast cells that lack the 
endogenous VPS74 (Tu, Tai et al. 2008). Whether GOLPH3 and GOLPH3L indeed have 
similar roles in the localisation o f the Golgi enzymes in mammals remains to be better 
defined.
Recently, it has been shown that similar to yeast VPS74, the Drosophila 
homologue of GOLPH3, known as Rotini, mediates the intra-Golgi recycling of Extosin 
(EXTs), a cis-medial Golgi glycosyltransferase that mislocalises to the TGN after Rotini 
knock-down and to the transitional ER upon Rotini overexpression (Chang, Chang et al. 
2013). Unlike in yeast or Drosophila, the reduction in GOLPH3 levels in mammalian cells 
leads to relocalisation of core 2 N-acetylglucosaminyltransferase 1 to the ER, rather than to 
the TGN or to post-Golgi compartments (Ali, Chachadi et al. 2012).
Golgi glycosyltransferase retention/recycling mechanisms are not mutually 
exclusive, so it is likely that many signals that involve distinct regions of these molecules 
act together to mediate the efficient targeting of these enzymes to the Golgi apparatus.
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Figure 1.3 Models of glycosyltransferase retention within the Golgi apparatus
Mechanisms of protein-protein interactions (1, adapted from Banfield 2011), or based on 
lipid exclusion (2, adapted from Banfield 2011), as well as molecular machinery based on 
COGs (3, adapted from Cottam and Ungar 2012) and Vps74/GOLPH3 (4, adapted from Tu 
and Banfield 2010), might cooperate together to promote the correct localisation of 
glycosyltransferases within the Golgi apparatus.
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1.4 Mechanisms of intra-Golgi transport
After synthesis in the ER, cargo proteins move to and traverse the Golgi complex, an 
organelle that is composed of stacks of membranous cistemae where cargo is modified by 
glycosylating enzymes during transport. The mechanism of intra-Golgi transport has been 
studied for decades, and most, if  not all, of the possible avenues of investigation have been 
documented or hypothesised. It is fair to say, however, that transport through the Golgi 
remains one of the main unsettled questions in membrane biology (Pfeffer 2007). Different 
models have been proposed to explain how proteins move from the cis- to trans-Golgi, and 
below I summarise the main experimental observations that argue in favour or against each 
model.
1.4.1 Cisternal-progression model
This model was the first to be proposed to explain the mechanisms of intra-Golgi transport. 
Based on morphological evidence, it indicates that proteins that leave the ER by carriers 
reach the cis side of the Golgi apparatus, where they fuse with each other to form the first 
cis cistema. The entire cistemae then progress in the cis-to-trans direction, changing their 
position over time and acting in this way as a shuttle for cargo proteins. During this 
process, a new cistema forms at the cA-Golgi face, and the last trans cistema is consumed 
at the trans face. The main evidence supporting this model is based on the observation that 
large algal scales were exclusively present in the lumen of the Golgi cistemae (Becker, 
Bolinger et al. 1995) and absent from peri-Golgi vesicles.
1.4.2 Vesicular-transport model
The discovery that the composition of each cistema in a given Golgi stack has a specific 
biochemical identity pointed to the inability of the cisternal-progression model to explain 
such a distribution. A reformulation of the intra-Golgi transport models to reconcile these
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observations led to the vesicular-transport model. The view of the Golgi complex as a 
stable compartment in which the cistemae are static and the cargo is moved forward by 
shuttling COPI transport vesicles (see Fig. 1.4, 2) represents the basic concept of this 
model (Farquhar and Palade 1981).
Strong evidence in favour of this hypothesis came from in vitro experiments, in 
which cells lacking N-acetylglucosaminyl transferase I and expressing VSVG were fused 
with wild-type cells, and surprisingly VSVG with incomplete glycosylation achieved the 
normal glycosylation profile after this fusion event (Rothman 1987). This evidence, 
coupled with the identification and characterisation of the machinery involved in vesicle 
formation and fusion (Rothman and Wieland 1996), gave further support to the vesicular- 
transport model.
Further in vitro studies showed that VSVG can enter 50-60-nm diameter COPI- 
coated vesicles (Ostermann, Orci et al. 1993), and moreover, other cargoes, like proinsulin, 
were detected in a subset of vesicles (Orci, Stamnes et al. 1997). In contrast, COPI vesicles 
were also reported to be depleted of other cargoes, like apolipoproteins E and B (Dahan, 
Ahluwalia et al. 1994), casein submicelles (Clermont, Xia et al. 1993), and the polymeric 
immunoglobulin receptor (Malsam, Satoh et al. 2005; Gilchrist, Au et al. 2006). The most 
striking evidence that cannot be explained by the vesicular-transport model concerned the 
transport of alga scales and procollagen, because they are too large to enter the 50-60-nm 
diameter COPI vesicles.
1.4.3 Cisternal-progression/ maturation model
The cisternal-progression/ maturation model stems from a re-evaluation o f the old 
cisternal-progression model to accommodate the well-established differential compositions 
of the Golgi cistemae. This thus includes the concept of recycling of the Golgi resident 
enzymes, which move from the distal to proximal cistemae via retrograde COPI-coated
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carriers, in synchrony with cisternal progression (see Fig. 1.4, 1). A key experiment 
specifically designed to test the hypothesis of cistemal-maturation model came from the 
study of the trafficking of procollagen, which was shown to progress from the cis- to the 
trans-Golgi in 10 min to 15 min without ever leaving the lumen of the cistemae (Bonfanti, 
Mironov et al. 1998). Later, using a reversibly polymerisable system, it was suggested that 
"megavesicles" might be involved in the intra-Golgi transport o f such large cargoes. 
(Volchuk, Amherdt et al. 2000).
Nevertheless, other evidence supporting the cistemal-progression/maturation model 
was obtained when EM experiments showed that small transmembrane proteins (VSVG) 
and a large polymer (procollagen) traverse the Golgi apparatus at similar rates, without 
entering into COPI vesicles or “megavesicles” (Mironov, Beznoussenko et al. 2001), and 
the identification of Golgi resident enzymes in COPI vesicles (Martinez-Menarguez, 
Prekeris et al. 2001) (although this finding remains controversial; see Orci, Amherdt et al. 
2000).
Due to the peculiar characteristics of yeast Golgi, in which the cistemae are not 
arranged in stacks, two different laboratories visualised cisternal maturation in vivo 
through live-cell imaging. Using different fluorescence markers for early and late Golgi, it 
was possible to follow the change in composition of a Golgi cistema over time due to the 
recycling of the Golgi residents (Losev, Reinke et al. 2006; Matsuura-Tokita, Takeuchi et 
al. 2006). Compartment maturation has also been reported to exist in other transport steps 
of the cell, and specifically in the endocytic pathway, where early endosomes acquire the 
characteristics of late endosomes through the loss of Rab5 and the subsequent acquisition 
of the Rab7 marker (Rink, Ghigo et al. 2005).
The relatively recent discovery of Golgi heterotypic tubular connections by EM and 
tomography studies (Marsh, Volkmann et al. 2004; Tmcco, Polishchuk et al. 2004), and 
their implication for the recycling of Golgi enzymes, have suggested a possible integration
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of the progression/maturation models (see review of Glick and Luini 2011). The 
identification of the enzyme responsible for the formation of intercistemal tubular 
continuities and their implication in transport through the Golgi apparatus (San Pietro, 
Capestrano et al. 2009) highlighted the importance of these carriers in the context of intra- 
Golgi transport. Nevertheless, if  heterotypic tubular connections are responsible for the 
recycling of Golgi enzymes or for anterograde transport of small secretory cargos, or for 
both, still needs to be fully defined (see review by Glick and Luini 2011).
1.4.4 Rapid partitioning within a two-phase membrane system
According to the rapid-partitioning model, the Golgi apparatus is viewed as a single
compartment that contains two lipid sub-domains: the processing domain that is 
responsible for the glycosylation reactions, and the export domain where cargo proteins are 
exported out o f the Golgi (see Fig. 1.4, 4; Patterson, Hirschberg et al. 2008). This 
relatively recent model changed the mainstream prospective of the Golgi apparatus 
drastically. This formulation of a new model for intra-Golgi transport was suggested by 
fluorescence microscopy experiments in which membrane cargoes, soluble cargoes, and 
large cargoes exited the Golgi apparatus with exponential kinetics, which means that the 
cargoes can exit the Golgi at every level o f the Golgi stack. This study also presented 
evidence that cargo proteins and Golgi resident enzymes occupy different regions o f the 
same compartment, similar to an earlier published observation (Pelhaman et al 2001). 
Many other key observations cannot be easily explained by the rapid-partitioning model, 
like the order of the glycosylation reactions on glycolipids and glycoproteins, which 
reflects their cis-to-trans distribution in the Golgi (Emr, Glick et al. 2009), or the 
progressive condensation of procollagen and secretory granules observed in the Golgi. 
Moreover, the exit of cargoes from the cis side o f the Golgi that is predicted by this rapid- 
partitioning model has never been observed. Notwithstanding the weaknesses o f this
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model, a plausible way to explain the mono-exponential kinetics o f the cargo exit comes 
from the observation that most cargoes are concentrated in the post-Golgi compartment, 
the TGN, at steady-state and the observed exit of cargoes from the Golgi actually reflects 
the exit from the TGN (see review by Glick and Luini 2011).
1.4.5 Cisternal-progenitor model
This recent model was proposed by (Pfeffer 2010) and it represents an evolution of the old 
vesicular-transport concept in which the Golgi apparatus is still viewed as a static 
compartment with anterograde cis-to-trans movement of the cargoes resulting from a 
process known as the Rab cascade. There are two main premises for the cisternal- 
progenitor model: first of all, it is known that the Golgi ribbon undergoes continuous 
lateral fission and fusion events, and thus it is a metastable structure. Nocodazole treatment 
fragments the Golgi ribbon into ministacks, and its wash-out leads to rapid ribbon 
reformation (see review by Thyberg and Moskalewski 1985), thus demonstrating the 
metastable nature of the mammalian Golgi ribbon. The second premise is based on a 
mechanism named Rab conversion, in which the sequential recruitment of active Rab 
GTPases appears to be important during cargo progression between early and late 
endosomes (Rink, Ghigo et al. 2005). Moreover, this cascade has been shown to exist in 
the yeast Golgi apparatus, where a Rab GTPase recruits a GEF for the subsequent-acting 
Rab, thus providing vectoriality to the transport that occurs in the Golgi apparatus (Ortiz 
and Novick 2006). Based on these premises, the progenitor model explained the cis-to- 
trans movement of cargo proteins in the mammalian Golgi apparatus through sequential 
steps, the first being a segregation mechanism of a specific Rab into each cistemae, 
followed by the fission and homotypic fusion events that are responsible for the 
directionality o f anterograde intra-Golgi transport (see Fig. 1.4,3; Pfeffer 2010).
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This progenitor model, however, has several weaknesses; indeed, the presence of a 
specific Rab in each mammalian Golgi cistema still requires experimental evidence, and 
furthermore, the fission and fusion events have never been visualised during the maturation 
of the yeast Golgi (Losev, Reinke et al. 2006; Matsuura-Tokita, Takeuchi et al. 2006).
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Figure l .4 Models of intra-Golgi transport.
I, 2 (from Nilsson, Au et al. 2009); 3 (from Pfeffer 2010); 4 (from Patterson, Hirschberg et 
al. 2008).
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CHAPTER 2
Objectives
Despite the development of new technologies in the scientific field in the last few years, 
the mechanisms of intra-Golgi transport are still an important and unresolved issue in cell 
biology. Different models have been proposed to explain how secretory proteins cross this 
complex organelle, but still none of them have gained a consensus among the scientific 
community. All of the models described above can be mainly grouped into two types: one 
based on stable cistemae, and the other on ‘maturing’ cistemae. One of the main 
differences between them is the behaviour of the Golgi resident enzymes that are supposed 
to remain fixed within static cistemae. In the case o f stable cisternal models (Rothman and 
Wieland 1996; Patterson, Hirschberg et al. 2008; Pfeffer 2010), the Golgi enzymes are 
considered to be stably localised to the cistemae, while they are thought to be dynamic in 
the case of the cistemal-progression/maturation model. In this latter case, to maintain their 
intra-Golgi distribution, the Golgi enzymes need to be recycled back during the 
progression of the cistemae (see reviews Nakano and Luini 2010; Glick and Luini 2011). 
This mechanism enjoys a degree of experimental support (Bonfanti, Mironov et al. 1998); 
(Matsuura-Tokita, Takeuchi et al. 2006), but cmcial evidence that Golgi enzymes maintain 
their position in the stack by recycling in step with transport is still missing in mammalian 
cells (Emr, Glick et al. 2009).
Here, I have studied the dynamics o f the Golgi-resident proteins, and in particular 
the glycosylation enzymes, to determine how their dynamics are coupled to those o f the 
cargoes that are transported through the Golgi apparatus. To this end, I have engineered 
Golgi resident constructs that can be reversibly polymerised to prevent their entry into
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carriers, and examined the transport behaviour of these constructs in monomeric and 
polymeric states. Under these conditions, the stable and maturing cistemae models predict 
very different behaviour. The Golgi progression/maturation model predicts that, if  a 
suitably modified c/s-Golgi resident protein is prevented from recycling, it will remain 
within the lumen of a cistema and hence move to the trans-side of the stack at the rate of 
cisternal progression (see Fig. 2.1; Bonfanti, Mironov et al. 1998). This condition might be 
achieved by reversibly polymerising a suitable czs-resident construct, as polymers might be 
too large to enter recycling vesicles or tubules, and/or incompatible with the vesicular 
membrane curvature. If then, once at the trans-Golgi, such a polymer were depolymerised, 
the resulting monomers might re-enter vesicles and recycle back to the c/s-Golgi. In 
contrast, according to the stable cistemae models, a Golgi resident, such as an enzyme, 
should localise in the stack independently o f its ability to enter Golgi carriers (see Fig. 2.1).
Thus, in this study, I used an assay to manipulate the aggregation state o f the Golgi 
resident enzymes, and I studied their behaviour through the combination o f confocal and 
EM microscopy techniques.
The objectives o f this study were:
Engineering and characterisation of Golgi resident enzymes in terms of their 
localisation and reversible polymerisation properties;
Examination of the entry o f the engineered Golgi resident enzymes into 
vesicular/tubular carriers under aggregation/disaggregation conditions;
Study o f the fate of a czs-Golgi resident after its polymerisation in the Golgi apparatus; 
Study of the Golgi functions under polymerisation conditions of the engineered Golgi 
resident enzyme.
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Figure 2.1 Experimental strategy.
Polymerisation of a c/s-Golgi enzyme as a tool to discriminate between the stable versus 
maturation models of intra-Golgi transport. Each model predicts very different behaviour 
for a polymerised c/s-Golgi resident enzyme. The red arrow indicates the fate o f the same 
cistema over time.
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CHAPTER 3
Materials and methods 
3.1. Cell culture. 
3.1.1 Materials.
Dulbecco’s modified Eagle’s medium (DMEM) and calf serum (CS) were from Nitrogen 
(UK). Foetal calf serum (FCS), penicillin, streptomycin, trypsin-EDTA and L-glutamine 
were from Biochrom KG (Berlin, Germany). All o f these reagents were as 1 0 x stock 
solutions. All of the plastic-ware was from Coming (NY, USA) or Falcon (NJ, USA). 
Filters (0.45 and 0.2 pm) were from Albet (USA).
3.1.2 Growth media.
HeLa cells were cultured in RPMI supplemented with 4.5 g/1 glucose, 2 mM glutamine, 
100 U/ml penicillin, 100 pg/ml streptomycin and 10% foetal calf semm (FCS). Normal rat 
kidney (NRK) cells were grown in DMEM supplemented with 4.5 g/1 glucose, 2 mM 
glutamine, 100 U/ml penicillin, 100 pg/ml streptomycin, and 10% FCS.
3.1.3 Growth conditions.
All of the cell lines were grown in a controlled atmosphere in the presence o f 5% CO2 at 
37 °C. The cells were grown in flasks until 90% confluence. To detach the cells from the 
surface of the flasks, the medium was removed and 0.25% trypsin-EDTA in normal saline 
solution was added for 2-5 min at room temperature (RT). Complete medium was then
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added back to block the protease action, and the cells were collected in a plastic test-tube 
and centrifuged at 300x g  for 5 min. The pellet o f cells was resuspended in fresh medium 
and seeded into new plastic flasks.
3.2 Transformation of bacteria using heat shock
3.2.1 Materials
Bacto™ tryptone, Bacto™ yeast extract, and agar were from Becton, Dickinson and 
Company (USA). NaCl was from Carlo Erba (Italy). Glycerol was from Merck (Germany).
3.2.2 Procedures
The plasmid DNA (1 pg/pl) was diluted in 10 mM Tris-HCl/ EDTA to a final 
concentration of 50 ng/pl. One microliter of the DNA (50 ng/pl) was added to 200 pi 
competent bacteria previously thawed on ice. After gentle mixing, the bacteria were 
incubated on ice for 20 min, heat shocked for 90 s at 42 °C, and after addition of 800 pi LB 
broth, incubated under shaking (200 rpm) at 37 °C for 45 min. The bacteria were plated on 
LB agar containing the appropriate selective antibiotic, and incubated overnight (O/N) at 
37 °C. The following day, an isolated bacterial colony was picked and inoculated into 2 ml 
LB broth containing the appropriate antibiotic. The culture was incubated at 37 °C O/N, 
and 700 pi 50% sterile glycerol was added to 700 pi bacterial culture, which was then 
stored at -80  °C.
3.3 Cell transfection
3.3.1 Constructs preparation
(i)The pcDNA4B-FM3-HA construct (FM-HA) was prepared as follows:
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Three copies of tandem FM (mutant FK506 binding protein (FKBP-Phe36Met)) domains, 
with an HA tag at the C-terminal region was amplified using polymerase chain reaction 
from PC4EN-FM3 (from Ariad Pharmaceuticals www.ariad.com: (Rivera, Wang et al. 
2000) vector using the forward primer: 5 ’-cgggatccagaaaggtgtctagaggagtgcaggtg-3 ’ and 
reverse primer: 5’-cggaattcttatgcgtagtctggtacgtcgtacggataagatccgtaataactagtttc-3\ The
product was digested with BamHl and EcoRl and subcloned into BamHl/EcoRl digested 
pcDNA4B (Invitrogen).
(ii)The GALT-FM construct was prepared as follows:
The cytosolic, transmembrane, and luminal stem domains of p-l,4-galactosyltransferase 
(GALT) was amplified using polymerase chain reaction from GALT-GFP construct (Cole, 
Smith et al. 1996) using the forward primer: 5’-cccaagcttatgccgggcgcg-3’ and reverse 
primer 5’-cggggtaccagaaaggtgtctagaggagtg-3\ The product was digested with Hindlll and 
Kpnl and subcloned into the Hindlll/Kpnl-digested FM-HA to obtain GALT-FM.
(iii) The MANI-FM construct was prepared as follows:
The cytosolic, transmembrane, and luminal stem domains of mouse Golgi alpha 1,2- 
mannosidase IB was amplified using polymerase chain reaction from pEYFP-Nl- 
Mannosidasel construct (Marra et al., 2001) using the forward primer: 5’-
ccaagcttatgcccgtggggggcctg -3’ and reverse primer 5’- ggggtaccaaacagatccttgtcacgcag -3’. 
The product was digested with Hindlll and Kpnl and subcloned into the HindllVKpnl- 
digested FM-HA to obtain MANI-FM.
3.3.2 Materials
TrisHCl and EDTA were from SIGMA (USA). The Qiagen plasmid kits for large-scale 
plasmid DNA preparation was from Qiagen (USA).
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3.3.3 Large scale preparation of plasmid DNA
A single colony of XL-1 Blue Escherichia coli bacteria (Stratagene, USA) transformed 
with the plasmid of interest was inoculated into 500 ml LB broth plus the appropriate 
selective antibiotic. After 15 h to 20 h of incubation, the bacteria were collected by 
centrifugation at 6000 rpm (4000 x g) in a JA10 rotor for 10 min at 4 °C, and processed 
according to the manufacturer instructions (Quiagen plasmid kits). The DNA obtained was 
resuspended in TE buffer (10 mM TrisHCl, 1 mM EDTA, pH 7.5) to a final concentration 
of 1 mg/ml, and stored at -20 °C.
3.3.4 TransIT-LTl-reagent-based cell transfection
The cells were plated onto glass coverslips in 24-well plates, or into 3.5-cm glass-bottomed 
petri dishes or 1 0 -cm petri dishes, in normal culture medium at a concentration suitable to 
have 50% to 70% confluence for transfection. The day after, a transfection mixture was 
prepared by diluting the TransIT-LTl reagent in OptiMEM culture medium, which was 
incubated at RT for 5 min. The DNA was then added to the transfection mixture, which 
was gently shaken, and kept at RT for another 20 min, to allow the DNA-TransIT-LTl 
reagent complex to form. The cells were then incubated prior to the assays with the 
transfection mixture for 24 h at 37 °C, in complete medium without antibiotics, as reported 
for each experiment.
3.4 Radioactive labelling
The method used was essentially as described previously (Bonifacino 2001), with small 
modifications as described below. HeLa cells transfected with the construct for MANI 
linked to the FK506 binding protein (FKBP)-domain mutant (FM) (MANI-FM) were 
cultured in the presence of API2998 for 12 h, and then the media was substituted with one 
containing 0.05 mCi/ml radiolabelled ([3 5S]) cysteine and methionine, and further cultured
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for 24 h in the presence of API2998. The cells were then lysed in RIPA buffer (150 mM 
NaCl, 20 mM Tris, pH 8.0, 0.1% [w/v] sodium dodecyl sulphate [SDS], 0.5% sodium 
deoxycholate, 1% [v/v] Triton X-100) and centrifuged at 14,000 rpm (20000 x g)for 5min, 
and the supernatant was used for immunoprecipitation.
3.5 Immunoprecipitation procedures
3.5.1 Materials
Lysis buffer: RIPA buffer (150 mM NaCl, 20 mM Tris, pH 8.0, 0.1% [w/v] SDS, 0.5% 
[w/v] sodium deoxycholate, and 1% [v/v] Triton X-100), and protease inhibitor cocktail 
(Complete Mini EDTA free; Roche)
3.5.2 Procedures
After the radioactive labelling experiment, the cells were washed with phosphate-buffered 
saline (PBS), lysed with RIPA buffer, and then centrifuged at 13,000x g  for 10 min at 4 °C. 
Then 500 pg lysate was incubated O/N with 5 pg mouse anti-HA antibody or 5 pg anti- 
hMANI antibody. Then 30 pi Protein-G Sepharose beads (Amersham) were added and 
incubated for an additional 1 h at 4 °C. After washing 3 times with lysis buffer and twice 
with lysis buffer without Triton X-100, the bound protein was eluted by boiling the 
samples for 10 min in 100 pi Laemmli buffer. The immunoprecipitate was resolved by 
SDS-PAGE followed by autoradiography. The intensity of the bands was quantitated using 
ImageJ.
3.6 General biochemical procedures
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3.6.1 Materials
SDS, glycine, Trizma base, Ponceau red, polyoxyethylenesorbitan monolaurate (Tween- 
20), ammonium persulphate, and N,N,N’,N’-tetramethylethylenediamine (TEMED) were 
from Sigma-Aldrich (WI, USA). Acrylamide stock solution, at 40% (w/v) acrylamiderbis- 
acrylamide (37.5:1), was from Eurobio (France). Acetic acid was from Carlo Erba (Italy). 
Secondary antibodies conjugated with horse radish peroxidase (HRP) and directed against 
mouse or rabbit IgGs were from Calbiochem (CA, USA). The ECL reagents were from 
Amersham Pharmacia Biotech (NJ, USA).
3.6.2 Solutions
Running buffer: 25 mM Trizma base, 200 mM glycine, 0.1% (w/v) SDS.
SDS sample buffer: 62.5 mM Tris-HCl, pH 6 .8 , 2% (w/v) SDS, 10% (v/v) glycerol, 5% 
(v/v) C-mercaptoethanol and 0.1% (w/v) bromophenol blue.
Transfer buffer: 25 mM Trizma base, 200 mM glycine, 20% (v/v) methanol.
TBS: 150 mM NaCl, 20 mM Tris-HCl, pH 7.5.
TTBS (TBS plus Tween 20): 0.05% (w/v) Tween 20, 150 mM NaCl, 20 mM Tris-HCl, pH 
7.5.
Blocking solution for Western blotting: 1% (w/v) bovine serum albumin (BSA) in TTBS; 
5% skimmed milk in TTBS.
3.6.3 Assembly of polyacrylamide gels
Two 16 cm x 18 cm plates were used for standard gels. The plates were assembled to form 
a chamber using two 1.5-mm plastic spacers aligned along the lateral edges of the plates. 
The plates were then fixed using two clamps and mounted into a plastic base which sealed 
the bottom. All of the materials were from Hoefer Scientific Instruments (Germany). The 
‘running’ polyacrylamide gel was prepared by mixing water, 40% (w/v)
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acrylamide:bisacrylamide solution, 1.5 M Tris-HCl, pH 8 .8 , 10% (w/v) SDS, to have the 
selected concentration of acrylamide in 375 mM Tris-HCl, 0.1% (w/v) SDS. Then, 0.06% 
(w/v) ammonium persulphate and 0.06% (v/v) TEMED were added, and the solution was 
mixed and poured into the gap between the plates, leaving ~5 cm for the stacking gel. Soon 
after pouring, the gel was covered with a layer of water and left at RT for ~2 h. The water 
layer was then removed. The ‘stacking’ polyacrylamide gel was prepared by mixing water, 
40% (w/v) acrylamide:bisacrylamide solution, 500 mM Tris-HCl, pH 6 .8 , 10% (w/v) SDS, 
to have 4% (w/v) acrylamide, 125 mM Tris-HCl, 0.1% (w/v) SDS. Then, 0.1% (w/v) 
ammonium persulphate and 0.07% (v/v) TEMED were added, and the solution was mixed 
and poured onto the ‘running’ gel. Immediately, a 15-well or 10-well comb was inserted 
between the glass sheets and the apparatus was left for 1 h at RT.
3.6.4 Evaluation of protein concentrations
Protein concentrations were evaluated using a commercially available bicinchoninic acid 
(BCA) protein assay kit (Bio-Rad Laboratories, UK), according to the manufacturer 
instructions.
3.6.5 SDS-PAGE sample preparation and running
Samples were prepared by adding SDS sample buffer, incubating at 100 °C for 5-10 min in 
a multi-block heater (Lab-Line, IL, USA), cooling to RT, briefly centrifuging and finally 
loading onto an SDS gel. One well was loaded with 5 pi Rainbow recombinant protein 
molecular weight markers (Amersham Pharmacia Biotech, NJ, USA) or with 5 pg Low 
Molecular Weight Standards (Bio-Rad Laboratories, UK). The gel was then transferred 
into the electrophoresis apparatus (Hoefer Scientific Instruments, NJ, USA), and the 
electrophoresis was carried out under constant current of 8  mA (for O/N runs) or 40 mA 
(for ~4-h runs).
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3.7 Western blotting
3.7.1 Protein transfer onto nitrocellulose
The polyacrylamide gels were soaked for 15 min in transfer buffer, placed on a sheet of 
3MM paper (Whatman, NJ, USA) and covered with a nitrocellulose filter (Schleicher & 
Schuell, Germany). The filter was covered with a second sheet of 3MM paper, to form a 
‘sandwich’, which was subsequently assembled into the blotting apparatus (Hoefer 
Scientific Instruments, NJ, USA). The protein transfer was carried out at 500 mA for 4 h, 
or at 125 mA O/N. At the end of the run, the sandwich was disassembled, and the 
nitrocellulose filter was soaked in 0.2% Ponceau red (Sigma-Aldrich, WI, USA) and 5% 
(v/v) acetic acid for 5 min to appropriately visualise the protein bands, and then rinsed with 
5% acetic acid to remove excess unbound dye.
3.7.2 Probing the nitrocellulose with specific antibodies
The nitrocellulose filters were cut into strips with a razor blade. The strips containing the
proteins of interest were incubated in the blocking solution for Western blotting plus 1% 
(v/v) BSA or 5% (w/v) milk powder (for ECL-based detection) for 1 h at RT, and then 
with the primary antibody diluted to its working concentration in the blocking solution for 
Western blotting (see Table 2.1, for the list o f antibodies used in the Western blotting 
experiments). After a 2-3-h incubation at RT, or an O/N incubation at 4 °C, the antibody 
was removed and the strips were washed twice in TTBS, for 10 min each. The strips were 
next incubated for 1 h with the appropriate HRP-conjugated secondary antibody diluted in 
the blocking solution for Western blotting (anti-rabbit: 1:10,000; anti-mouse: 1:10,000) 
and washed twice in TTBS, for 10 min each, and once in TBS for 3 min. After washing,
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the strips were incubated with the ECL reagents, according to the manufacturer 
instructions for ECL-based detection.
3.8 Experimental conditions for MANI-FM polymerisation
HeLa cells were transfected with the MANI-FM construct (see section 3.3.1) using Mirus
transfection reagent, following the manufacturer instructions. After 24 h transfection in the 
presence of 1 pM AP12998 at 37 °C, the media was changed and 1 pM fresh AP12998 was 
added for 30 min at 37 °C. The cells were then treated with 33 pM nocodazole for 3 h in 
the presence of 1 pM API2998, and 50 pM cycloheximide (CHX) was added for the last 
30 min at 37 °C. Importantly, the MANI-FM levels at the Golgi remained constant 
throughout this period. The API2998 was then washed out o f a subset of samples for the 
indicated times in the presence of CHX and nocodazole. All of the experiments were 
carried out in the presence of nocodazole and CHX, unless otherwise indicated.
3.9 MANI-FM sedimentation/ polymerisation assay
The sedimentation assay to reveal the polymerisation status of MANI-FM was performed 
as described previously (Volchuk, Amherdt et al. 2000). In brief, after treatment, the cells 
were lysed in lysis buffer (1% [v/v] Triton X-100, 20 mM Hepes, pH 7.4, 100 mM KC1, 2 
mM EDTA, 1 mM dithiothreitol, and protease inhibitor cocktail [Roche]) at 4 °C for 30 
min. The lysate was then centrifuged at 20,000x g  for 10 min, and the pellet and 
supernatant fractions were separated and analysed by SDS-PAGE and immunoblotting.
3.10 Sucrose gradient centrifugation
Sucrose gradients (5%-20% sucrose) in lysis buffer (1% [v/v] Triton X-100, 20 mM Hepes, 
pH 7.4, 100 mM KC1, 2 mM EDTA, 1 mM dithiothreitol, and protease inhibitor cocktail 
[Roche]) were prepared and cooled to 4 °C. The cells were treated and lysed as described
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in section 3.9, and a volume of 500 pi of clarified lysate was layered on the top of the 
gradient. The gradients were centrifuged at 36,000 rpm in a SW-41 rotor (Beckman 
Coulter) for 20 h at 4 °C. The sucrose gradients were fractionated, and each fraction was 
precipitated with trichloroacetic acid. The trichloroacetic-acid-precipitated proteins were 
analysed by SDS-PAGE (Section 3.6.5).
3.11 Infection of cells with vesicular stomatitis virus
The infectious stocks of the temperature-sensitive (ts-0-45) mutant strain of VSV were 
prepared by Antonella Di Campli (Instituto di Biochimica delle Proteine, Consiglio 
Nazionale delle Richerche, Naples, Italy) according to (Bergmann 1989). For each 
infectious stock, the optimal working concentration was experimentally defined as the 
lowest concentration causing 100% infection of HeLa cells, judged by staining of the viral 
membrane glycoprotein (VSVG).
The system of VSV is often used in membrane-traffic studies (Bergmann 1989), as 
the virus has a very small genome and does not have the machinery for protein translation, 
post-translational processing, or transport of its membrane proteins. Indeed, the VSV 
genome codes for only five proteins, among which there is an integral membrane 
glycoprotein (VSVG). As the virus inhibits the synthesis of host cell proteins, the total 
translational capacity of the cell is devoted to the synthesis of the viral proteins. In the ts-0- 
45 strain, VSVG bears a point mutation that causes its misfolding at temperatures higher 
than 39.5 °C. The misfolded protein is retained in the ER and excluded from transport 
carriers involved in ER-to-Golgi transport (Rose and Bergmann 1983; Schnitzer, Dickson 
etal. 1979).
The cells were washed twice in serum-free culture medium and incubated with the 
diluted VSV infectious stock for 1 h at 32 °C. For HeLa-cell infection, VSV was diluted 
1:40 in serum-free medium. After infection, the cells were washed with PBS to remove
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extracellular viral particles, and then they were subjected to different transport protocols as 
described in Chapter 4 (Section 4.4.1).
3.11.1 Acquisition of endoH resistance
VSVG has been used extensively as a marker to study the biochemical and molecular basis 
for transport along the exocytic pathway both in vivo (Tisdale, Bourne et al. 1992) and in 
vitro (Davidson and Balch 1993). VSVG is a type I transmembrane protein that has two N- 
linked carbohydrate chains and is transported from the ER to the Golgi apparatus and then 
sequentially through the cis-, medial and trans-Golgi compartments. Its transport through 
the Golgi can be followed by the processing of two oligosaccaride chains from the high 
mannose endoH-sensitive form (which is found in the ER and in the pre-Golgi 
compartments) to the endoH-resistant form (which is found in the Golgi stack). The 
processing intermediates can be easily distinguished by SDS-PAGE (Davidson and Balch 
1993). The first endoH-resistant form corresponds to the transport of VSVG from the ER 
to the early Golgi compartment (endoH-resistance develops after its transport to the medial 
Golgi), where one or both of the oligosaccaride chains becomes endoH resistant by the 
action of the resident 1,2-mannosidases and glycosyltransferases (Davidson and Balch 
1993; Tisdale, Bourne et al. 1992). The subsequent transport o f VSVG to the TGN results 
in the appearance of the fully processed form, which contains two complex endoH- 
resistant oligosaccarides (Davidson and Balch 1993, Tisdale, Bourne et al. 1992). The 
appearance of sequential processing intermediates allows the direct examination of the 
effects of drug treatments on both ER-to-Golgi and intra-Golgi transport in the same 
experiment (Davidson and Balch 1993; Tisdale, Bourne et al. 1992).
50
3.11.2 Materials
RIPA buffer (150 mM NaCl, 20 mM Tris, pH 8.0, 0.1% [w/v] SDS, 0.5% [w/v] sodium 
deoxycholate, and 1% [v/v] Triton X-100), sodium citrate, P-mercaptoethanol, and 
protease inhibitors were from SIGMA (USA). EndoH was from New England BioLabs 
(USA). 4-(2-hydroxyethyl)-monosodium salt (Hepes) was from Merck (Germany).
3.11.3 VSVG transport assay
HeLa cells transfected with MANI-FM (see Experimental conditions for MANI-FM 
polymerisation; Section 3.8) were seeded in Multiwell™ 6 -well tissue culture plates in 
normal culture medium, at a concentration suitable to have 50% to 70% confluence on the 
day of the experiment. The cells were washed twice with medium containing 20 mM 
Hepes without serum, and then incubated for 1 h at 32 °C with VSV diluted in the same 
medium. The cells were washed and incubated for 2 h with complete medium containing 
20 mM Hepes at 32 °C to allow the synthesis of VSVG to proceed. The cells were 
subsequently washed, incubated with complete medium at 40 °C for 3 h, then washed 
twice, incubated with complete medium containing 20 mM Hepes and shifted to 32 °C for 
0, 30, 60, 120, 180 min. At each time point, the cells were washed twice with PBS on ice 
and then lysed in RIPA buffer (150 mM NaCl, 20 mM Tris, pH 8.0, 0.1% [w/v] SDS, 0.5% 
[w/v] sodium deoxycholate, and 1% [v/v] Triton X-100) at 4 °C for 30 min. The lysates 
were clarified by centrifugation at 20000x g  for 10 min. The supernatants were treated with 
endoglycosidase H in the endoH buffer (0.05 M sodium citrate, pH 5.5) at 37 °C O/N. The 
treated samples were then resolved by SDS-PAGE, and then Western blotting was carried 
out using an anti-VSVG antibody.
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3.12 Immunofluorescence microscopy
3.12.1 Materials
Glass coverslips were from Carlo Erba (Italy). Mowiol was from Calbiochem (Germany). 
Paraformaldehyde was from Electron Microscopy Sciences (EMS, USA). Saponin and 
NH4CI were from Fluka (Sigma, USA). 4-(2-Hydroxyethyl)-monosodium salt (Hepes) was 
from Merck (Germany).
3.12.2 Sample preparation
The cells were grown on coverslips and fixed with 4% paraformaldehyde for 10 min at RT, 
and then permeabilised with 0.2% saponin in blocking solution (PBS containing 1% BSA, 
50 mM NH4CI) followed by incubation with the antibodies to the antigen of interest in the 
same solution at 4 °C overnight, followed by second antibodies labelled with Alexa Fluor 
dyes (Invitrogen). The coverslips were then mounted in the mounting media (16% [w/v] 
Mowiol 4-24 [EMD Millipore] and 30% [v/v] glycerol in PBS) and examined under a 
confocal microscope (LSM710; Carl Zeiss)
3.12.3 Confocal microscopy and line scanning
The images were acquired with a pinhole set to 1 and under non-saturation conditions 
using a 63 x objective (1.4 NA). The images were acquired using the Zen software system 
(Carl Zeiss). The line scan analysis was performed as described previously (Dejgaard, 
Murshid et al. 2007). In brief, images of stacks stained for GM130, TGN46, and MANI- 
FM were acquired as described earlier. Only cells with a moderate level of expression were 
considered for the analysis. Cells that expressed high levels of the MANI-FM construct 
were avoided, as this leads to the localisation of the protein at the PM (-20% of the cells). 
Golgi stacks with clearly separated GM130-stained and TGN46-stained zones were
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identified and used for the analysis. A line was drawn in the middle o f the stacks along the 
cis-trans direction, and the fluorescence intensity of each stained marker along this line 
was plotted. The images obtained were then processed using Metamorph 7.7.3.0 (Universal 
Imaging), with the “Image with Zoom” function for presentation. At least 30 stacks were 
examined per treatment, and a representative image is shown. For the computational 
coalescence o f line scans, the normalised line scans to be coalesced were plotted together 
and coalesced using the Gaussian curve fitting option of GraphPad Prism version 5.0 
software. The normalisation of the distances was carried out by considering the start of the 
GM130 peak as 0, and the end of the TGN peak as 1.
3.13 Pre-embedding techniques
The name of these techniques arises because the labelling is performed before the sample 
embedding. Briefly, the samples are chemically fixed and the antigen is labelled using a 
specific primary antibody that is recognized by a secondary antibody conjugated with 
ultra-small gold particles (Section 3.13.2). The detection of the gold particles is almost 
unequivocal, and they can be exactly quantitated; however, one limitation o f the use o f  
colloidal gold conjugates (5, 10, 15 nm gold particles) has been that generally they do not 
penetrate cells, even after permeabilisation. Therefore, their use in pre-embedding 
immuno-staining has up to now been restricted both to the labelling o f cell-surface 
antigens, either for scanning or transmission EM, and for tracing endocytic pathways in 
living cells. Recently, 1.4-nm gold conjugates that can penetrate cells and tissues much 
more readily have been used successfully to immunolabel intracellular structures. Ultra­
small immuno-gold probes label more efficiently than do the larger colloidal gold particles 
(1.4> 5> 10> 15 nm). The only drawback of this approach is that to detect 1.4-nm gold 
probes by conventional transmission EM, the gold enhancement (see Section 3.13.2) 
reaction has to be developed and this procedure typically produces particles o f variable
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diameters, unlike the 5, 10, and 15 nm particles that instead are uniform in diameter. 
Another advantage of this approach is the possibility to cut serial consecutive sections of 
the specimen, which can be used for three-dimensional (3D) reconstruction of organelles 
using electron tomography (see Section 3.16).
3.13.1 Materials
Fab’ fragments conjugated with nanogold (1.4-nm gold particles) were from Nanoprobes 
(USA). Goldenhance™ -EM was from Nanoprobes. Multiwell™ ( 6  well) tissue-culture 
plates were from Becton Dickinson (France). Grids, osmium tetraoxide, paraformaldehyde 
and glutaraldehyde were from Electron Microscopy Sciences (EMS, USA). Sodium 
cacodylate, saponin, NH4 CI and the epoxy resin kits were from Fluka (Sigma, USA). BSA 
was from Sigma (USA). Potassium ferrocyanide, ethanol and acetone were from Carlo 
Erba (Italy). Tris-HCl was from Merck (Germany).
3.13.2 Gold enhancement
The cells were grown in 6 -well plates, and were fixed with a mixture of 4% 
paraformaldehyde and 0.05% glutaraldehyde in 0.15 M Hepes for 5 min at RT, and then 
placed in 4% paraformaldehyde in 0.15 M Hepes for 30 min at RT. Afterwards, the cells 
were washed 6  times in PBS at RT, and incubated with blocking solution for 30 min at RT. 
Finally, the cells were incubated with the primary antibody diluted in blocking solution 
(see Tab 3.1) overnight at 4 °C. On the following day, the cells were washed 6  times with 
PBS at RT, and incubated with goat anti-mouse Fab’ fragments coupled to 1.4-nm gold 
particles (diluted in blocking solution, 1 :1 0 0 ) for 2  h and finally washed six times with 
PBS at RT. Meanwhile, the activated Goldenhance™-EM was prepared according to the 
manufacturer instructions, and 300 pi was added into each of the wells. The reaction was 
monitored by conventional light microscope, and was stopped after 5 min to 10 min when
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the cells had turned “dark enough”, by washing several times with PBS. Osmification 
followed: the cells were incubated for 1 h at RT with a 1:1 mixture of 2% osmium 
tetraoxide in distilled water and 3% potassium ferrocyanide in 0.2 M sodium cacodylate 
pH 7.4, and then rinsed six times with PBS and then with distilled water. The samples were 
then dehydrated: 3x 10 min in 50% ethanol; 3x 1 0  min in 70% ethanol; 3x 10 min in 90% 
ethanol; and 3x10  min in 100% ethanol. The samples were subsequently incubated for 2 h 
in a 1:1 mixture of 100% ethanol and epoxy resin (EPON) at RT; the mixture was then 
removed with a pipette and finally samples were embedded for 2 h in epoxy resin at RT. 
The resin was polymerised for at least 10 h at 60 °C in an oven.
3.14 Post-embedding techniques
The name of these techniques arises because the labelling is performed after the sample 
embedding. The cryosectioning technique is the most important technique for post­
embedding sub-cellular immunocytochemistry; indeed, cryosections have been used to 
immunolabel several different antigens and they have also been applied to other powerful 
techniques, such as in-situ hybridisation.
Cryosectioning offers three major advantages compared to pre-embedding 
techniques: (i) easier and faster sample preparation; (ii) both chemical and structural 
integrity o f tissues are better preserved; (iii) possibility to perform double staining o f the 
same specimen to precisely localise one antigen with respect to another.
In addition, it has been demonstrated that the cryosection technique appears to be 
the most sensitive detection method available for some antigens, and the only detection 
method available for other antigens, where antibodies do not label resin sections. 
Moreover, both the ease and rapidity o f sample preparation for cryosectioning makes this a 
convenient way of performing routine immunocytochemistry localisation.
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3.14.1 Materials
Multiwell™ ( 6  well) tissue culture plates were from Becton Dickinson (France). 
Acetylated BSA (BSA-c™) was from Aurion (Wageningen, The Netherlands). Protein A 
conjugated with 5, 10, and 15 nm gold particles was provided by J. Slot (Utrecht 
University, Utrecht, The Netherlands). Grids, paraformaldehyde and glutaraldehyde were 
from Electron Microscopy Sciences (USA). Uranyl acetate and glycine were from Fluka 
(Sigma, USA). Cold fish skin gelatin, BSA, and methyl cellulose were from Sigma (USA). 
Sucrose was from Carlo Erba (Italy). Whatman 50 filter papers were from Whatman (UK).
3.14.2 Ultrathin cryosectioning
The cells were fixed by adding to the culture medium the same volume of a mixture of 0.2 
M PIPES-Hepes-EGTA-magnesium (PHEM) buffer, 4%  paraformaldehyde, 2% 
glutaraldehyde for 2 h, and finally stored in storage solution O/N (0.1 M PHEM buffer, 
0.5% paraformaldehyde, in distilled water). After washing with 0.15 M glycine buffer in 
PBS, the cells were scraped and pelleted by centrifugation, embedded in 10% gelatin, 
cooled on ice, and cut into 0.5-mm blocks in the cold room. The blocks were infused with 
2.3 M sucrose, which acts as a cryo-protectant, and then placed onto small specimen pins. 
The pins were frozen by immersion in liquid nitrogen, and quickly transferred to a pre­
cooled (-60 °C) cryo-chamber fitted onto a ultramicrotome (Leica ultracut R), for 
trimming to a suitable shape. The sections were cut at -120 °C using a dry diamond knife, 
and collected on the knife surface. The sections were retrieved from the knife by picking 
them up on a small drop of a 1:1 mixture o f 2.3 M sucrose and 2% methyl cellulose, and 
transferring tern onto formvar-coated and carbon-coated specimen grids. The samples were 
processed for immuno-labelling as described in the following section. Ultrathin 
cryosections were cut by Claudia Puri (Telethon Institute of Genetics and Medicine, Via P. 
Castellino 111, Napoli, Italy).
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3.14.3 Labelling of cryosections
During immuno-labelling, the grids were kept floating on drops o f buffered saline solution 
with the section side in the liquid. The back of the grid was kept dry and the section side 
was kept hydrated at all times.
The grids were washed onto 100 pi droplets of PBS for 10 min and then 
additionally washed 3x 3 min with 0.02 M glycine in PBS, pH 7.4. The grids were 
incubated for 10 min in 0.5% BSA-c™ in PBS, and then incubated on 10 pi droplets of 
diluted primary antibody for 1 h (as indicated in Table 3.1). The grids were washed six 
times with 0.1% BSA-c™ in PBS, and then either directly incubated with Prot A-gold (10 
nm) for 30 min, if  the primary antibody was a polyclonal one, or with a rabbit anti-mouse 
immunoglobulin antibody (bridge antibody) and then with protein A golds, if  the primary 
antibody was a monoclonal one. The grids were rinsed six times with 0.1% BSA-c™ in 
PBS and post-fixed with 1% glutaraldehyde in 0.15 M Hepes for 5 min. In case of double 
immuno-labelling, the above described procedure was repeated with the incubating of the 
grids with Prot A-gold with different sizes (e.g., 5 nm). Finally, the grids were washed 5x 
1 min in distilled water, and stained for 10 min in 1.8% methyl cellulose plus 0.4% uranyl 
acetate on ice. The grids were retrieved with a stainless steel loop, and placed onto a piece 
of a Whatman 50 filter paper at an angle of 45°. After air-drying, the grids were ready to be 
examined under the electron microscope.
3.15 Immuno-electron microscopy: data acquisition and quantitation
The samples were then examined under an iTEM transmission electron microscope (JEOL
Ltd.). Random sampling for the Golgi stacks was performed, with the only criterion for 
selection being the presence o f gold label on Golgi stacks that were sectioned 
perpendicularly to the plane of cistemae. The stacks were imaged at a magnification of  
20,000 or 30,000 using a Morada CCD camera with the iTEM image acquisition software
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(JEOL Ltd.). Some cells (-20% of the total) expressed high levels of MANI-FM and 
showed this construct at the PM. These cells were discarded. The cells selected for 
quantitation typically had 2-15 gold particles per stack. The images were analysed using 
the iTEM image analysis platform (Olympus). The polarity o f the stacks was assigned 
based on compositional and morphological criteria. The former was based on immunogold 
staining with anti-GM130 antibodies, a cA-Golgi marker. The morphological criteria were 
based on the presence of clathrin buds or vesicles at the TGN side of the Golgi apparatus, 
and of typical fenestrated cistemae (c/s-Golgi). The clathrin buds/ vesicles localised at the 
TGN at variable distances from the stack (from very close, to up to 500 nm from the last 
/nms-cistema). Only those stacks where the association of clathrin buds to the trans side 
was unambiguous were considered for quantification. The two criteria (morphological and 
compositional) were always in agreement. Several Golgi structures were evaluated. The 
number of cistemae varied from three to five. For quantification, we classified these as cis, 
medial, or trans. Cis indicated the cA-most cistema in the case o f a stack with three or four 
cistemae, and the two cis-most cistemae in the case o f a stack with five cistemae (here, the 
linear density was the mean of the two). Trans was the last (trans) cistema. Medial was the 
remaining one or two central cistemae. Vesicles were round profiles of 50 nm to 80 nm in 
diameter, present within 200 nm of the rims of the stack. Tubules were elongated profiles 
with length/width ratios greater than two. Of note, the analysis of thin sections precludes 
the discrimination of dissociated carriers and inter-cistemal tubular connections, and so 
quantification of tubules includes both of these. The cisternal rims were the most 
peripheral 1 0 0  nm of the cisternal profiles, and the rest of the cistema was considered as 
the central cisternal part. All images were evaluated by three independent observers in a 
blind fashion. For surface density calculations, the number of gold particles associated with 
a structure was counted, and the membrane length was measured using the iTEM software. 
The linear density was then expressed as linear density (number of gold particles/pm).
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When gold particles localised close to more than one structure, they were assigned to the 
closest structure. The number o f Golgi stacks evaluated is specified in the legends.
3.16 Electron microscopy tomography
For EM tomography, the sample preparation and tomographic reconstruction were carried 
out essentially as described previously (Trucco, Polishchuk et al. 2004). In brief, HeLa 
cells were fixed with 2% gluteraldehyde for 2  h at room temperature, and the samples were 
then processed, stained, dehydrated, and Epon embedded. The samples were sectioned 
(2 0 0 -nm sections), and gold particles were placed on the surfaces o f the plastic sections 
and examined by EM (Tecnai-12; FEI). The Golgi profiles with well-preserved structures 
were identified and the images were acquired at tilt angles of +65° to -65° at 1° intervals, 
with a magnification of 26,500 using a Veletta CCD digital camera. The tomographic 
reconstruction was carried out using the Inspect 3D (FEI).
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Table 3.1 List of antibodies used in the present study.
Antibody Dilution Type Source
Anti-TGN46 1:800 (IF) Sheep AbD Serotec
Anti-GM130 1:1000 (IF); 1:50 (EM) Mouse BD
Anti-HA 1:1000 (IF); 1:300 (EM) Mouse Covance
Anti-P-COP 1:20 (EM) Rabbit Thermo Fisher Scientific
Anti-GALT 1:400 (IF) Rabbit Sigma-Aldrich
Anti-hMANI 1:100 (IF) Rabbit Sigma-Aldrich
Anti-VSVG 1:8000 (WB) Rabbit Bethyl Laboratories, Inc.
Alexa Fluor 488 1:400 (IF) Donkey Invitrogen
Alexa Fluor 568 1:400 (IF) Donkey Invitrogen
Alexa Fluor 633 1:400 (IF) Donkey Invitrogen
Dylight 405 1:100 (IF) Donkey Jackson Laboratories
Anti-GFP 1:400 (IF); 1:1000 (WB) Rabbit Abeam
Anti-GAPDH 1:10000 (WB) Mouse Santa Cruz Biotechnology
Anti-TNG38 1:500 (IF) Rat AbD Serotec
IF, immunofluorescence; EM, electron microscopy; WB, Western blotting.
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CHAPTER 4.
Results
4.1 Engineering and characterisation of Golgi resident enzymes: localisation 
and reversible polymerisation properties
4.1.1 Engineering of the Golgi resident enzymes
The experimental approach that I used to reversibly manipulate the polymerisation state of  
the Golgi resident enzymes is based on the well-standardised system of a regulated 
secretion/aggregation kit from Ariad Pharmaceuticals (original reference Rivera, Wang et 
al. 2 0 0 0 ; www.ariad.com).
Briefly, this uses a mutant FK506 binding protein (FKBP-Phe36Met) that is known 
as ‘FM’ that spontaneously dimerises. The dimer can be dissociated by using AP12998, 
which binds to the FK506 binding domain. Depending on the number o f FM domains in 
the protein, the size of the polymer that is formed can be regulated.
To engineer a polymerisable Golgi resident enzyme, I fused the Golgi targeting 
portions (i.e., cytosolic tail, transmembrane domain, stem region) of mouse 1,2-MANI-B 
(Becker, Haggarty et al. 2000), which is a c/s/medial-Golgi enzyme (Dunphy and Rothman 
1983; Marra, Maffucci et al. 2001), with three tandem FM domains and with an HA tag for 
detection (MANI-FM; Fig. 4.1.1a). In addition, I prepared a similar construct using the 
targeting portions of the trans-Golgi enzyme GALT (GALT-FM; Cole, Smith et al. 1996). 
Once polymerised, those constructs can generate large two-dimensional submembrane 
networks (Fig. 4.1.1b).
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MANI-FM was then expressed in HeLa cells, which were pulsed with radiolabelled 
([3 5S]) cysteine and methionine to confirm the expression of the protein, which appears to 
be at a level of two- to three-fold higher than that of the endogenous human a-1 , 2  
Mannosidase IB (hMANI) (Fig. 4.1.1c, d).
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Figure 4.1.1 Domain composition of MANI-FM.
Three FM domains followed by an HA tag were fused to the C-terminal end of the Golgi- 
targeting portion (i.e. cytosolic, transmembrane, luminal stem domains) of mouse MANI. 
(b) Scheme of MANI-FM polymerisation and depolymerisation in the absence and 
presence, respectively, of AP12998. (c) To quantify the amount of MANI-FM present in 
the transfected cells relative to the endogenous enzyme (hMANI), transfected HeLa cells 
were pulsed with radiolabelled ([35S]) cysteine and methionine for 24 h, and the 
endogenous and transfected proteins were immunoprecipitated (see Methods, Section 3.5) 
and examined by autoradiography. Under the immunoprecipitation conditions, most of the 
target proteins were immunoprecipitated. (d) Quantitation of the levels of MANI-FM 
relative to that of the endogenous enzyme (hMANI).
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4.1.2 Controlled aggregation/disaggregation state of MANI-FM
To study the polymerisation/depolymerisation kinetics of MANI-FM, I carried out a
sedimentation assay on the basis that in the absence of AP12998, after detergent 
solubilisation o f cells and low speed centrifugation, MANI-FM should be largely 
recovered in the insoluble pellet fraction, because its dimensions are bigger than its 
monomeric status. On the other hand, if  the cells are incubated in the presence of API 2998, 
MANI-FM should move into the soluble detergent supernatant (Volchuk, Amherdt et al. 
2000).
As expected, in the monomeric state (+AP12998), MANI-FM was in the 
supernatant whereas after API2998 wash-out it shifted to the pellet, reflecting the 
formation of the large MANI-FM polymers (Fig. 4.1.2a). This shift started 5 min after 
API2998 wash-out, and it was complete within 15 min. Sucrose gradient centrifugation 
confirmed that MANI-FM shifts from a monomeric to a polymeric state within 15 min of 
AP12998 removal (Fig. 4.1.2c). I then added AP12998 to polymeric MANI-FM (see Fig. 
4.1.2a) to induce depolymerisation: MANI-FM shifted back to the supernatant rapidly (Fig. 
4.1.2b).
Thus, MANI-FM polymerises upon API2998 removal in -10-12 min, and it 
depolymerises with API2998 addition in <5 min.
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Figure 4.1.2 Reversible polymerisation of MANI-FM.
MANI-FM polymerisation as revealed using a sedimentation assay, (a) HeLa cells 
expressing MANI-FM were cultured in the presence of 1 pM A PI2998 (+AP), and then
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the API2998 was washed out for the indicated times before cell lysis and low-speed 
centrifugation to separate the pellet and supernatant fractions. The MANI-FM in these 
fractions was then quantified by gel electrophoresis and Western blotting. MANI-FM shifts 
from the supernatant (S) to the pellet (P) in <15 min. (b) MANI-FM depolymerisation. 
HeLa cells expressing MANI-FM had the API2998 washed out over 15 min (-AP; see 
panel a) and then 1 pM API2998 was added again to the cells for the indicated times. 
MANI-FM shifts back to the supernatant in <5 min. (a, b) Data are means ±SEM, from 
three independent experiments, (c) Sucrose gradient centrifugation confirms that MANI- 
FM moves to the pellet after 15 min of API2998 removal. The experiment was performed 
as in a, but after cell lysis the samples were processed for high-speed centrifugation in a 
sucrose gradient (20%-50% sucrose). Then, the different fractions were collected and 
precipitated with trichloroacetic acid. The proteins were analysed by SDS-PAGE and 
immunoblotting.
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4.1.3 MANI-FM localises mainly to the Golgi apparatus, like the full- 
length protein
The MANI-FM construct contains only the targeting motifs of the mouse a -1,2 
Mannosidase IB (see Fig. 4.1.1a) without the catalytic domain. To determine whether the 
MANI-FM is targeted/retained in the Golgi like the full-length protein, I compared the 
efficiency of targeting/retention of MANI-FM with that of the full-length protein (mouse- 
a-l,2-Mannosidase IB fused to GFP; MANIfl-GFP).
In cells expressing low-to-medium levels of MANI-FM and MANIfl-GFP, these 
proteins localised only at the Golgi apparatus, whereas in highly expressing cells (~20% of 
the cell population), these two constructs were at both the Golgi and the PM (see Fig. 
4.1.3a-d). Thus, the Golgi targeting and retention properties of MANI-FM do not appear to 
differ considerably from those of the transfected full-length MANIfl-GFP. Similar 
observations have been reported for other Golgi enzymes (Berger 2002). In the localisation 
experiments described below, I included only cells expressing low-to-medium levels of 
MANI-FM.
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Figure 4.1.3 Monomeric MANI-FM is mainly retained in the Golgi apparatus
HeLa cells expressing high or low levels of MANI-FM (+AP12998; a  and c) or M A N Ifl- 
G FP  (b  and d ) were fixed and labelled for surface-localised MANI-FM and M A N Ifl-G F P  
using an anti-HA monoclonal antibody and anti-GFP antibodies, respectively, without 
permeabilisation (red). Later, the cells were permeabilised and labelled for the proteins 
present internally (green; anti-HA polyclonal antibody for MANI-FM; M A N Ifl-G F P  was 
not labelled). In cells expressing high levels of MANI-FM and M A N Ifl-G F P , both are 
present at the PM. Bars: (a )  18 pm; (b ) 16 pm; (c and d ) 20 pm.
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4.1.4 Characterisation of reversibly polymerisable Golgi resident 
enzymes
To define suitable conditions to examine the intra-Golgi localisation of MANI-FM in its 
monomeric or polymeric states (+AP12998), I first used nocodazole, which fragments the 
Golgi apparatus into separate but structurally and functionally “normal” stacks (ministacks; 
Cole, Sciaky et al. 1996; Trucco, Polishchuk et al. 2004). The advantages o f the ministacks 
are that: (a) they provide good resolution between the c/s-Golgi and trans-Golgi by 
immunofluorescence (Shima, Haidar et al. 1997); Fig. 4.1.4.1a-d); (b) they lack interstack 
tubular zones, which facilitates the analysis of peri-Golgi vesicles/tubules under EM 
(Trucco, Polishchuk et al. 2004); and (c) they are physically isolated from other stacks, 
which rules out the possibility of exchange of cargo through contacts with adjacent stacks, 
like in the Golgi ribbon (Trucco, Polishchuk et al. 2004; Pfeffer 2010). Secondly, I emptied 
the ER of MANI-FM by cycloheximide treatment for 30 min before starting the 
observations, to ensure that all o f the MANI-FM that I examined was localised in the Golgi 
apparatus (see Materials and methods; Section 3.8).
Using these conditions (see Fig. 4.1.3), I assessed the distribution of monomeric 
MANI-FM (+AP12998) in the Golgi cistemae and in peri-Golgi vesicles and tubules (as 
defined in Materials and methods; Section 3.15) using immuno-EM and stereology. 
MANI-FM showed higher linear density in the cis- > medial > trans-cistemae, similar to 
the localisation reported for the endogenous MANI enzyme (Dunphy and Rothman 1983; 
Marra, Maffiicci et al. 2001; Fig. 4.1.4.1e, h; and see also Fig. 4.4.1.2a). Moreover, 
MANI-FM was more concentrated at the rims than in the central parts o f the cistemae (Fig. 
4.1.4.1f, g, i), it was present in vesicles and tubules at concentrations 50% and 96%, 
respectively, o f that found in the cistemae (tubules here included both dissociated carriers 
and inter-cistemal tubular connections; see Materials and methods, Section 3.15; Fig. 
4.1.4.1j), and it was practically absent from the ER and in regions outside o f the Golgi 
stack area, including the PM.
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By confocal microscopy, MANI-FM (again in cells expressing low-to-medium 
levels o f the construct) localised between the CGN and the TGN (stained with the CGN 
and TGN markers GM130 and TGN46, respectively), in qualitative agreement with the 
EM data (Fig. 4.1.4.1k, 1). This MANI-FM localisation was similar to that of full-length 
MANI, and it was also similar to that seen in the intact Golgi apparatus o f NRK cells, 
where the c/s-Golgi and trans-Golgi can be easily distinguished, even without nocodazole- 
mediated dissociation (Fig. 4.1.4.2a-c).
I also examined the localisation of the GALT-FM construct. As monomers, GALT- 
FM localised in the trans- »  medial > cA-cistemae, as visualised by EM (Fig. 4.1.4.2d). 
Again, this represented a distribution that was similar to that o f the corresponding 
endogenous enzyme (Teasdale, D'Agostaro et al. 1992).
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Figure 4.1.4.1 MANI-FM localises to a c/s/medial position in the Golgi stack.
(a) Untreated HeLa cells show the typical ribbon-like structure of the Golgi apparatus. 
GM130 staining (green) and TGN46 (red) are shown, (b) Nocodazole treatment (33 pM 
for 3 h) fragments the intact Golgi ribbon into hundreds of ministacks spread throughout 
the cell. GM130 staining (green) and TGN46 (red) are shown, (c) Ministacks resulting 
from nocodazole treatment maintain their polarity, as seen by the clear separation o f 
GM130 (green) and TGN46 (red). A magnified image of a single isolated stack from (b). 
The white arrow across the stack was used for the line-scan analyses, (d) Fluorescence 
intensity distribution of markers along the line scan (c, arrow). The fluorescence intensities 
were normalised to their respective peak values. The image shown is representative of 
more than three independent experiments, and for the data shown, n = 10. Bars: (a, b) 15 
pm; (c) 1 pm. (e-g) HeLa cells expressing MANI-FM were cultured in the presence of
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Trans
API2998, and then fixed and processed for cryoimmuno-labelling with an anti-HA 
antibody (10-nm gold particles), (e) Localisation of MANI-FM in the c/Wmedial cistemae, 
with a clathrin bud (arrow) marking the trans side, (f) An example of the preferential rim 
distribution o f MANI-FM. (g) An enlargement o f f, with MANI-FM in a peri-Golgi carrier 
(arrowhead), (h-j) Quantification of the distribution of MANI-FM across the Golgi stacks 
(h), in the central versus the rim sections o f the cistemae (i), and in peri-Golgi vesicles and 
tubules (j). Data are means ±SEM, obtained from the analysis of 28 stack profiles, (k) 
Localisation of MANI-FM in a Golgi stack under confocal microscopy. MANI-FM (green) 
localises between GM130 (blue) and TGN46 (red). The white arrow across the stack was 
used for the line-scan analyses. The image is representative o f >30 stacks analysed. (1) 
Fluorescence intensity distribution of markers along the line scan (arrow in k). The 
fluorescence intensities were normalised to their respective peak values. The image and the 
corresponding quantitation are representative o f at least 30 Golgi ministacks from three 
independent experiments. For these data (e-1), n = 30. Bars: (e) 270 nm; (f) 240 nm; (g) 60 
nm; (k) 1 pm.
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Figure 4.1.4.2 The FM fusion proteins show appropriate sub-Golgi localisations.
(a-c) Localisation of MANI-FM in an intact Golgi ribbon of NRK cells. NRK cells 
expressing MANI-FM were cultured in the presence of A PI2998, fixed and stained for 
MANI-FM (green), GM130 (red), and TGN38 (blue). The enlargement in c (CROP) shows 
the co-localisation of MANI-FM with a czT-Golgi marker. The image is representative of 
>30 Golgi ribbon analysed, (d) HeLa cells transfected with GALT-FM in the presence of 
A PI2998 were fixed and stained for GALT-FM (anti-HA) using immunonanogold. The 
trans side of the stack was identified by clathrin-coated structures (arrowhead). The 
labelling is mainly present in the trans-most cistema of the stack. Bars: (a, b) 20 pm, (c) 3 
pm (d) 1 50 nm.
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4.2 Examination of the entry of the engineered Golgi resident enzymes into 
vesicular/tubular carriers under aggregation/disaggregation conditions
4.2.1 Polymerisation prevents entry of Golgi MANI-FM into peri-Golgi 
carriers
Based on the strategy that I decided to use to study the mechanisms of intra Golgi transport, 
an important aspect that needs to be explored is the possible entry of the MANI-FM 
polymer into Golgi vesicles/tubules. For this reason, I polymerised MANI-FM by 
removing API2998 for 15 min, and examined by EM the entry of the polymer into Golgi 
dissociative carriers. When polymerised, the concentration (as linear density) of MANI- 
FM in vesicles and tubules dropped by -90%, to barely detectable levels (Fig. 4.2.1.1a, b). 
Moreover, MANI-FM lost its concentration at the rims of the Golgi cistemae and was 
distributed randomly along the cisternal length (Fig. 4.2.1.1c and see also Fig. 4.6.1c). The 
Golgi morphology and the number of peri-Golgi vesicles and tubules did not change, 
except for a reduction in the surface area of the tubules (25%) (Fig. 4.2.1.Id). I also 
examined the entry of polymerised MANI-FM into Golgi tubules induced by the toxin 
brefeldin A (BFA; Lippincott-Schwartz, Donaldson et al. 1990). These tubules have a 
diameter of 40 nm to 80 nm (Lippincott-Schwartz, Donaldson et al. 1990), which is similar 
to that o f Golgi carriers, and they contain Golgi-resident proteins (Lippincott-Schwartz, 
Donaldson et al. 1990). An 8 -min treatment with BFA ( 6  pg/ml) induced the formation of 
numerous Golgi tubules that contained a cA-Golgi marker, the KDEL receptor (Fig. 
4.2.1.le , f). Polymeric MANI-FM did not enter these tubules, whereas MANI-FM 
monomers entered the tubules freely (Fig. 4.2.1.1e, f). Polymeric MANI-FM also reduced 
the number of BFA-induced tubules by 30% to 40%. However, this reduction did not 
prevent the redistribution of the Golgi resident enzymes, including MANI-FM into the ER 
after 30-min exposure to BFA (Fig. 4.2.1.2a-d). This is probably because o f the peculiar 
mode of BFA-induced retrograde transport. As live-imaging experiments have shown
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(Sciaky, Presley et al. 1997), the addition of BFA leads to the formation o f numerous 
tubules that contain the Golgi residents. When these tubules fuse with the ER, they cause a 
sudden collapse of the Golgi into the ER in seconds (“blink out”), which is possibly caused 
by tension-driven membrane flow (Sciaky, Presley et al. 1997). This complete collapse can 
presumably bring back to the ER even those proteins that do not actually enter the tubules.
I also examined whether polymeric MANI-FM and GALT-FM can enter vesicular/ 
tubular carriers derived from the ER (Bannykh and Balch 1997; Antonny and Schekman 
2001). Both MANI-FM and GALT-FM were retained in the ER when expressed in the 
absence of API2998, whereas after depolymerisation (+AP) they left the ER and rapidly 
reached the Golgi complex (Fig. 4.2.1.2e-h).
In summary, polymerisation prevents MANI-FM from entering Golgi vesicles and 
tubules, including BFA-induced tubules and ER-derived vesicular/tubular carriers. This 
effect o f polymerisation might be because: (a) the polymers are too large to enter the 
vesicles/tubules; (b) the polymers form a rigid platform that is incompatible with the 
curvature of the vesicles/tubules (Copic, Latham et al. 2012; or (c) the polymerisation 
hides the sorting signals that allow MANI-FM to enter into vesicles/tubules. The lack of 
entry of polymers into long BFA tubules and the concentration of polymers in the flat areas 
of the cistemae over the rims favour the second of these three possibilities (i.e., (b)).
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Figure 4.2.1.1 Polymerisation prevents MANI-FM entry into vesicles and tubules.
HeLa cells were transfected with MANI-FM in the presence of A PI2998, and then 
A PI2998 was removed for 15 min to induce polymerisation, (a) Polymeric MANI-FM (- 
AP for 15 min) is nearly absent in Golgi vesicles (arrowhead) and tubules. The trans side 
of the stack was identified by clathrin-coated buds (arrow), (b) Quantification of MANI- 
FM in vesicles and tubules. Polymeric MANI-FM (-AP) is strongly depleted in vesicles 
and tubules compared with the monomer (+AP). (c) MANI-FM distribution along the 
cisternal length, expressed as the ratio between the linear density (LD) in the rims versus 
the central part of the cistemae. MANI-FM shifts to a more central localisation after 
polymerisation. More than 20 stack profiles were analysed for each condition, (d) The 
membrane length of vesicles and tubules as a measure of the surface area, quantified and
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expressed as the perimeter, was not appreciably changed after polymerisation of MANI- 
FM. The total surface area o f the tubules decreased by ~25% after polymerisation of 
MANI-FM. (e) HeLa cells transfected with MANI-FM and KDEL receptor-GFP (KDELR- 
GFP) in the presence or absence of API2998 (for 10 min) were treated with 6  pg/ml BFA 
for 8  min to induce tubules emanating from the Golgi apparatus, and then fixed and stained 
for MANI-FM. MANI-FM enters BFA-induced tubules in the presence of API2998 
(monomers), but not in the absence o f API2998 (polymers), (f) The number of BFA- 
induced tubules positive for MANI-FM was quantified. At least 10 cells per condition per 
experiment were analysed, and the data are from three independent experiments. Data are 
means ±SEM. Bars: (a) 250 nm; (e, +AP) 15 pm; (e, +AP) 18 pm.
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Figure 4.2.1.2 Polymerisation of FM fusion proteins does not prevent their BFA- 
induced retrograde transport to the ER, but prevents their exit out of the ER.
HeLa cells expressing MANI-FM cultured in the continued presence of A P I2998 (a, b) or 
in the absence of A PI2998 for 10 min (c, d) were incubated with BFA for 30 min (b, d) in 
the presence or absence of A PI2998, respectively, and the localisation of the transfected 
proteins visualised by immunofluorescence. BFA treatment induces ER translocation of 
both monomeric and polymeric MANI-FM. (e-h) Polymerisation of FM fusion proteins 
prevents their exit out of the ER. (e) GALT-FM is retained in the ER in the absence of 
API 2998 (-AP) and is rapidly transported to the Golgi apparatus after addition of API 2998
(+AP). (f) Time kinetics of GALT-FM transport to the Golgi apparatus after addition of 
API2998. The curve fitting was done using a third-order polynomial function, (g) Similar 
to (e), MANI-FM transport was monitored, (h) Similar to (f), time kinetics of MANI-FM 
transport to the Golgi apparatus. Antibodies against endogenous GALT (e) and MANI (g) 
were used to identify the Golgi apparatus. About 20-30 cells were analysed per time point. 
Values are means ±SEM. Bars: (a-d) 16 pm; (e, g) 18 pm.
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4.3 Golgi function under polymerisation conditions of the Golgi resident 
enzymes
4.3.1 Polymerisation of MANI-FM does not affect the function of the 
Golgi apparatus
After confirming the reversible polymerisation of Golgi resident MANI-FM, I decided to 
determine whether MANI-FM polymerisation affects either the transport and glycosylation 
properties of the Golgi.
As a tool to study transport along the secretory pathway (ER-to-Golgi and Golgi-to- 
PM transport), I used the G-protein of the temperature-sensitive vesicular stomatitis virus 
(ts-045VSV) (see Methods; Section 3.11). This version o f VSVG is a temperature- 
sensitive mutant that accumulates in the ER at 39.5 °C due to incorrect folding (Rose and 
Bergmann 1983; Schnitzer, Dickson et al. 1979), but moves to the PM at the permissive 
temperature of 32 °C, providing a synchronised wave of movement o f cargo along the 
secretory pathway.
Initially, to study the transport of VSVG into and out of the Golgi apparatus, HeLa 
cells were co-transfected with VSVG-GFP and MANI-FM, and incubated overnight at 
40°C in the presence of AP 12998, which resulted in the accumulation o f VSVG-GFP in 
the ER and MANI-FM in the Golgi apparatus. Twenty-four h after transfection, the 
AP 12998 was washed out in a subset of samples kept at 40°C, to induce the polymerisation 
of MANI-FM while retaining VSVG in the ER. The rest of the experiment was carried out 
in the absence of API2998 for this subset, while the rest of the samples were maintained in 
the presence of API2998. The rest of the cells were then either shifted to 32°C for the 
indicated time to study the ER-to-Golgi transport of VSVG (Fig. 4.3.1.1), or shifted from 
40°C to 32°C for 20 min to accumulate VSVG-GFP in the Golgi apparatus, and then
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shifted back to 40°C for the indicated times to monitor the transport o f VSVG-GFP out of 
the Golgi (Fig. 4.3.1.2 a-c).
The observation that the transport of VSVG-GFP from the ER to the Golgi (Fig. 
4.3.1.1) and its transport out of the Golgi (Fig. 4.3.1.2 a-c) were not affected under MANI- 
FM polymerisation conditions implies that the intra-Golgi transport of the viral protein, 
VSVG, should also be normal (see Results, Section 4.5.1).
To study the glycosylation properties of the Golgi apparatus under polymerisation 
conditions of MANI-FM, I monitored the acquisition of endoH resistance o f the VSVG 
(Fig. 4.3.1.2 d). Under these experimental conditions, this was also not affected (Fig.
4.3.1.2 e; see Methods 3.11).
These observations indicated that the transport of VSVG into (Fig. 4.3.1.1) and out 
of the Golgi apparatus (Fig. 4.3.1.2 a-c) as well as the glycosylation of VSVG (Fig. 4.3.1.2 
d, e) all occurred at normal rates, suggesting that MANI-FM polymerisation does not 
perturb Golgi function.
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Figure 4.3.1.1 MANI-FM polymerisation does not affect the ER-to-Golgi transport of 
VSVG-GFP.
Transport of VSVG-GFP from the ER to the Golgi was quantified by measuring the 
fluorescence intensity o f VSVG-GFP in the Golgi region, which was not affected by the 
polymeric state of MANI-FM (+AP, monomer; -AP, polymer) (a, b) HeLa cells were 
transfected with both MANI-FM and VSVG-GFP in the presence of API2998, and then 
incubated at 40°C for 24 h. (b) The API2998 was washed out at 40°C to polymerise the
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MANI-FM in the Golgi apparatus and retain the VSVG-GFP in the ER, and after 10 min 
the cells were placed at the permissive temperature (32°C) for the indicated time to allow 
VSVG arrival at the Golgi. The same protocol in (b) was also applied in (a), but in 
presence of API2998 for the entire duration of the experiment, (c) The quantification was 
carried out by measuring the fluorescence intensity of the VSVG-GFP at the Golgi 
apparatus, as normalised to its total intensity in the cell. The assay was carried out with the 
Golgi ribbon intact, with nocodazole not included in these experiments. At least 20 cells 
per time point per experiment were analysed, and the results are from three independent 
experiments. Data are means ±SEM. Bars: (a, b) 18 pm.
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Figure 4.3.1.2 MANI-FM polymerisation does not affect the transport of VSVG-GFP 
out of the Golgi as well as its processing.
The transport of VSVG-GFP out o f the Golgi (quantified as in Fig. 4.4.1.1) was not 
affected by the polymeric state of MANI-FM (+AP, monomer; -AP, polymer), (a, b) HeLa 
cells were transfected with both MANI-FM and VSVG-GFP in the presence o f AP12998, 
and then incubated at 40°C for 24 h. (b) The API2998 was washed out at 40°C to 
polymerise the MANI-FM in the Golgi apparatus and to retain the VSVG-GFP in the ER,
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and after 10 min the cells were placed at the permissive temperature (32°C) for 20 min to 
accumulate VSVG-GFP in the Golgi (Time 0). The same protocol in (b) was also applied 
in (a), but in the presence of API2998. The cells were then shifted back to 40°C in the 
absence (b) and presence (a) o f AP 12998, to prevent further entry of VSVG-GFP into the 
Golgi, and to monitor the exit of the VSVG-GFP that was present in the Golgi apparatus. 
The exit of VSVG-GFP from the Golgi was quantified by measuring the intensity of the 
VSVG-GFP fluorescence at the Golgi, normalised to the total VSVG-GFP fluorescence of 
the cell over time, as shown in (c). At least 20 cells per time point per experiment were 
analysed, and the results are from three independent experiments. Data are means ±SEM. 
Bars: (a, b) 18 pm. (d) VSVG glycosylation as measured by acquisition of resistance to 
endoH (EndoFT, endoH resistant; EndoHs, endoH sensitive) was not affected by the 
polymeric state of MANI-FM (+AP, monomer; -AP, polymer). The assays were carried 
out using intact Golgi ribbon in the absence of nocodazole. (e) Quantification o f the 
acquisition of endoH resistance represented as the fraction of VSVG that was resistant to 
digestion by endoglycosidase H. Data are means ±SEM, from three different experiments.
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4.4 Fate of a c/s-Golgi resident after its polymerisation in the Golgi
4.4.1 Polymerisation causes MANI-FM to move forward in the Golgi stack
Finally, I sought to determine whether upon shifting from a monomeric to polymeric state, 
MANI-FM remains in its cis position, as would be predicted by the stable cistemae models, 
or if  it moves from the cis- to trans-cistemae, as would be predicted by cisternal 
maturation.
After API2998 removal (0 min), the MANI-FM peak shifted from the cis- to the 
medial cistemae (at 12 min), and then to the /nms-cistema (at 20 min; Fig. 4.4.1.1a-e; and 
see also Fig. 4.4.1.2). Considering that polymerisation lags behind by 10 min to 12 min 
after API2998 washout (Fig. 4.1.2a), the intra-Golgi transport rate of polymeric MANI- 
FM was similar to that reported for procollagen and VSVG (Mironov, Beznoussenko et al. 
2001), both of which have been proposed to move by cisternal maturation.
A difficulty in the interpretation of these data (Fig. 4.4.1.1d) is that according to the 
cistemal-maturation model, 12 min after API2998 removal (MANI-FM polymerisation), 
the c/s-cisterna should be empty of MANI-FM, yet it appears to still contain measurable 
levels o f this construct. This apparent discrepancy is most likely because the 
polymerisation of MANI-FM is not instantaneous, but rather takes several minutes to reach 
completion after API2998 removal (Fig. 4.1.2a). Hence, during this time interval, the 
residual monomeric MANI-FM fraction can recycle backwards into the c/s'-cistema. By 
light microscopy, the MANI-FM peak shifted away from GM130 (cis) and towards 
TGN46 (trans) within 20 min of API2998 removal, in agreement with the EM data (Fig. 
4.4.1.3a-d; and see also Fig. 4.4.1.4). Later, MANI-FM moved from the Golgi apparatus to 
assume a diffuse/punctuate distribution (Fig. 4.4.1.5b) and began to be degraded, 
presumably in the lysosomes (Fig. 4.4.1.5c), whereas monomeric MANI-FM was as stable 
as the endogenous MANI enzyme (Fig. 4.4.1.5d, e).
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Figure 4.4.1.1 Polymerised MANI-FM shifts from cA-/medial to fraws-Golgi cisternae 
(by EM)
(a, b) HeLa cells were transfected with MANI-FM in the presence o f A PI2998 (a), and 
then A PI2998 was removed for 20 min (b) to induce polymerisation o f MANI-FM. The 
MANI-FM (15-nm gold) shifted from the cA-cistemae (labelled with the cis marker 
GM130; 10-nm gold; arrowheads) to the /raws-cisternae after A PI2998 washout, (c-e) The 
distribution of MANI-FM across the stack at time 0 (c), 12 min (d), and 20 min (e) after 
A PI2998 washout, quantified and expressed as the linear density (L.D.) normalised to that 
of the maximum. The normalised linear density in the cA-cistemae is indicated in blue, in
15 hm MANI-FM 
10 nm GM130
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the medial, in green, and in the trans, in red. The schemes above the graphs depict the shift 
of the MANI-FM peak from the m/medial to the trans side of the Golgi stack. The 
intensities of the fill colours correspond to the normalised linear density of MANI-FM in 
the corresponding graphs (intensity scale on right). At least 20 stacks were analysed for 
each time point. Data are means ±SEM. Bars: (a, b ) 220 nm.
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Figure 4.4.1.2 Frequency distribution analysis and double immune-labelling with 
GM130 as a cis marker confirms that polymerisation of MANI-FM induces its shift 
from the cis to trans side of the Golgi apparatus.
HeLa cells expressing MANI-FM were cultured in the presence of A PI2998 (a) or after 
A PI2998 wash-out for 12 min (b) or 20 min (c) were fixed and processed for 
cryoimmunogold labelling. The trans-most cistema (trans side identified by the presence 
of clathrin coats) was named as C5, and the rest of the cistema assigned accordingly, with 
Cl being the fifth c/s-most cistema. The frequency distribution of the gold particles across 
the cistemae was quantified and is represented as the fractions of gold particles present in 
each cistema. Notably, 40% of the stacks had three cistemae, 50% had four cistemae, and 
only 10% of the stacks had five cistemae. Given the procedure used for the calculations, 
this accounts for the low values of gold particles in cistemae Cl and C2. Nevertheless, the
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shift o f the MANI-FM peak from the cw/medial to the trans side of the stack remains 
evident, as shown in the schemes above the graphs. The intensity of the filling colour 
corresponds to the number of gold particles o f MANI-FM (see intensity scale on the right). 
At least 20 Golgi profiles per time point were used for quantitation, and >100 gold 
particles per time point were counted from two independent experiments. For this 
experiment, n >20 for each time point, (d-f) HeLa cells expressing MANI-FM were 
cultured in the presence o f API2998 and then AP 12998 was washed out for 20 min before 
fixing and processing for cryoimmunogold labelling. The cis side of the stack was 
identified by GM130 (arrowheads; 10-nm gold). Polymerisation leads to the translocation 
of the MANI-FM (15-nm gold) to the trans side. Bars, (d-f) 180 nm.
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Figure 4.4.1.3 Visualisation of the shift of MANI-FM from the c/s-/medial to the trans- 
Golgi, by confocal microscopy.
(a, b) HeLa cells were transfected with MANI-FM in the presence o f API2998 (a), and 
API2998 was removed for 20 min (b), and then the cells were fixed and stained for 
MANI-FM (green), GM130 (blue), and TGN46 (red). The white arrow across the stacks 
was used for the line-scan analyses. The images are representative of >30 stacks analysed 
for each condition, (c, d) Fluorescence intensity distribution o f markers along the line scan 
(arrow in a, b). The fluorescent intensities were normalised to their respective peak values. 
The image and the corresponding quantitation are representative o f at least 30 Golgi 
ministacks from three independent experiments. For this experiment, n = 30. Bars: (a, b) 1 
pm.
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Figure 4.4.1.4 Computational coalescence of the line scans of 12 Golgi stacks.
HeLa cells expressing MANI-FM were cultured in the presence o f API2998 (a) or with 
API2998 washed out for 20 min (b), and fixed and processed for immunofluorescence 
labelling. The white arrows across the stacks were used for line-scan analyses. 
Representative stacks from the same pool of images from which Fig. 4.4.1.3 (a, b) was 
selected are shown, (c-f) Computational coalescence of the 12 graphs shown in a, b are 
shown in c, d, respectively, with the associated parameters used for curve fitting in e, f. 
This is a representative experiment out of three independent experiments. For this 
experiment, n = 12. Bars, (a, b) 1 pm.
94
aGM130 M130-MANI-FM
V
MANI-FM
v .
GM130-
• *r ^
JM130-MANI-FM,-
>
>
MANI-FM
CL
<+
b
CL
<
4  m
W " . . ,
• M
>  4$:
10 nm MANI-FM &
K D a
7 5 -
3 7 -
100-
3 7 -
5 0 -
3 7 -
5 0 -  
3 7 _  '
Time after CHX (50 ng/ml)
__________a d d i t io n ___________
O' 90' 180'
hMANI
GAPDH
MANIi .-G FP  
GAPDH
MANI-FM (+AP) 
GAPDH
MANI-FM (-AP) 
GAPDH
—  h M A N I
—  M A N I fl- G F P
—  M A N I-F M  ( + A P )
—  M A N F F M ( - A P )
O' 9 0  1 8 0
T im e  a f te r  C H X  ( 5 0  p g /m l)  
a d d it io n
Figure 4.4.1.5 Degradation of MANI-FM after prolonged polymerisation in the Golgi.
(a,b) HeLa cells were transfected with MANI-FM in the presence of A P I2998 (a), and 
A PI2998 was removed for 1 h (b), and then the cells were fixed and stained for MANI-FM 
(red), GM130 (green), and TGN46 (blue). The experiment was carried out in the absence 
of nocodazole to maintain the intact Golgi ribbon. The white arrowheads in b show the 
diffuse/ punctuate distribution of MANI-FM after prolonged Golgi polymerisation, (c) An 
example of MANI-FM in lysosomal-like structures after 1 h of A PI2998 wash-out. HeLa 
cells were treated as in (b) and then fixed and processed for cryoimmuno-labelling with an
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anti-HA antibody (10-nm gold particles), (d) HeLa cells expressing MANI-FM or 
MANIfl-GFP were cultured in the presence and absence o f AP 12998, and treated with 
cycloheximide for the indicated times, and the amounts of the MANI and GAPDH (loading 
control) proteins were analysed by lysis o f the cells followed by Western blotting. The 
quantification o f the blots in panel (d) is shown in (e). Whereas the polymeric MANI-FM 
(-AP) is degraded, the monomeric MANI-FM (+AP) is stable, like MANIfl-GFP and 
endogenous MANI. The results are typical of two independent experiments. Bars: (a, b) 5 
pm; (c) 100 nm.
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4.5 Intra-Golgi transport as well as Golgi morphology and the intra-Golgi 
localisation of endogenous MANI are not affected under MANI-FM 
polymerisation
4.5.1 Polymerised MANI-FM parallels the transport of VSVG-GFP 
within the Golgi
Once I had shown that the polymerised MANI-FM can move from the early to the late 
Golgi cistemae in the same time window as most o f the cargo known so far, I decided to 
determine whether this movement parallels the transport of VSVG, and at the same time, to 
determine whether the intra-Golgi transport of VSVG-GFP occurred at normal rates.
To test this hypothesis, HeLa cells were transfected for both VSVG-GFP and 
MANI-FM in the presence of AP 12998. After 24 h of incubation at 40°C to accumulate 
VSVG-GFP in ER (see Methods; Section 3.11), the temperature was shifted to 15°C for 1 
h to concentrate the VSVG-GFP in the VTCs (or ERGIC). Then the cells were placed at 
40°C again to prevent the export of newly synthesised VSVG-GFP from the ER in order to 
follow the transport of only the VSVG-GFP that had already accumulated in the ERGIC. 
In a subset of samples, AP 12998 was washed out 5 min before the temperature shift from 
15°C to 40°C, to induce the polymerisation o f MANI-FM in the Golgi apparatus (see 
protocol in Fig. 4.5.1.3g), The cells were then fixed at different times after the shift and 
labelled for both cis- and trans-Golgi markers to monitor the intra-Golgi localisation of 
VSVG-GFP and MANI-FM at the same time (Fig. 4.5.1.3a-f, h). Of note, to facilitate the 
line-scan quantification, the cells were pretreated for 3 h with nocodazole before the start 
of the experiment and the nocodazole was maintained throughout these experiments.
As can be seen from Fig. 4.5.1.3h, the VSVG-GFP was transported across the 
Golgi apparatus with identical kinetics under both polymerisation and non-polymerisation 
conditions for MANI-FM, suggesting that the polymerisation of MANI-FM does not affect
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the anterograde transport properties o f the Golgi apparatus. Moreover, the kinetics of 
forward movement of the polymerised MANI-FM paralleled the transport of VSVG-GFP, 
again indicating that the forward movement of the MANI-FM upon polymerisation 
probably occurs by the same mechanism by which anterograde cargo is transported. 
Polymerisation of MANI-FM did not modify the morphology and the surface area of the 
Golgi apparatus, either in the presence or absence of nocodazole (Fig. 4.5.1.4c, d); and the 
localisation of endogenous MANI was not affected by MANI-FM polymerisation (Fig. 
4.5.1.4a, b).
Thus, polymeric MANI-FM progresses from the cis- to the trans-Golgi without 
entering the carriers (vesicles/ tubules) at rates that are similar to those reported for 
procollagen and VSVG (Mironov, Beznoussenko et al. 2001), and without perturbing the 
function (see also Results; Section 4.3) and structure of the Golgi apparatus.
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Figure 4.5.1.3 MANI-FM polymerisation does not affect intra-Golgi transport of 
VSVG.
(a-f, h) VSVG-GFP parallels the transport of the MANI-FM polymer in the Golgi 
apparatus. HeLa cells co-expressing MANI-FM with VSVG-GFP were incubated 
overnight at 40°C in the presence of A PI2998, prior to shifting the temperature to 15°C for
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1 h in the presence of AP12998. Immediately after the 15 °C block (time 0 in h), the 
temperature was shifted back to 40°C in the presence (a-c) or in the absence (d-f) of 
API2998. The cells were fixed for the indicated time (see h) and processed for 
immunofluorescence. The good separation between the ds-Golgi marker (GM130) and 
trans-Golgi marker (TGN46) is shown in (a, d). After 20 min of the temperature shift from 
15°C to 40°C, the MANI-FM monomer (b) is in the c/s-medial Golgi (white arrowhead) 
whereas VSVG-GFP is localised in the trans-G olgi (c, see white arrowhead). In the 
absence of API2998 (-AP), both the MANI-FM polymer (e) and VSVG-GFP (f) move to 
the trans-G olgi (white arrowhead). The synchronisation protocol in (g) refers to images (a- 
f). (h) Quantification was carried out by normalised line-scan analysis (normalisation of 
distances was done by considering the middle of the GM130 peak as 0, and the middle of  
the TGN peak as 1). At least 30 stacks per time point per experiment were analysed, and 
the data are from two independent experiments. Data are means ±SEM. Bars: (a-f) 1 pm.
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Figure 4.5.1.4 Polymerisation of MANI-FM does not modify the Golgi structure and 
the localisation of endogenous MANI.
(a, b) MANI-FM polymerisation does not change the localisation o f endogenous MANI. 
HeLa cells co-transfected with MANI-FM and RablA-GFP were cultured in the presence 
of AP12998 (a) and API2998 was washed out for 20 min (b) before fixing and processing 
for immunofluorescence labelling. The experiment was carried out in the absence o f  
nocodazole to maintain the Golgi ribbon intact. The white arrow across the ribbon was 
used for the line-scan analyses shown above the images. The fluorescent intensities were 
normalised to their respective peak values. The images shown are representative of at least 
10 Golgi profiles examined for each condition from two independent experiments. For the 
experiment shown, n = 10. The polymerisation shifts MANI-FM (blue) from the cis (Rabl- 
GFP, green) to trans side (TGN46, red) of the Golgi, whereas the endogenous MANI 
(MANI endo, blue) maintains its c/s/medial position, (c, d) Morphology o f the Golgi stacks 
is not affected by MANI-FM polymerisation. HeLa cells expressing MANI-FM cultured in 
the presence of API2998 (+AP) or with API2998 washed out for 20 min (-AP), in the 
absence (c) or presence (d) of nocodasole, were fixed and processed by EM imaging. The 
length of the Golgi cisternal membranes were measured and expressed in pm. The cisternal 
membrane length (as a measure of surface area) did not change appreciably after MANI- 
FM polymerisation. Bars: (a, b) 20 pm.
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4.6 Depolymerisation of the Golgi resident enzyme restores its entry into peri- 
Golgi carriers and its intra-Golgi localisation
The observation that MANI-FM moves forwards in the stack when it is polymerised and is 
excluded from vesicular or tubular transport intermediates implies that monomeric MANI- 
FM normally recycles through these intermediates to maintain its cA-medial position. So 
far, however, direct evidence for the recycling of Golgi resident enzymes through the 
Golgi stack in synchrony with transport in the mammalian Golgi has been missing (Hoe, 
Slusarewicz et al. 1995; Malsam, Satoh et al. 2005).
I considered that if  the MANI-FM polymers were depolymerised in the trans- 
cistema, the resulting monomers should regain their entry into carriers, and could then 
recycle synchronously from the trans to the more proximal cistemae. To investigate this 
hypothesis, I first polymerised MANI-FM for 20 min to let the polymer reach the trans- 
cistema (Fig. 4.4.1.le), and then I depolymerised the MANI-FM by adding back API2998. 
At 20 min after API2998 wash-out, as expected, polymeric MANI-FM was 
homogeneously distributed in the trans-cistema (Fig. 4.6.1a; and see also Fig. 4.4.1.1b). 
Upon depolymerisation, MANI-FM rapidly (in 1.5-3.0 min) underwent the following 
distribution changes:
a) it became concentrated at the cisternal rims (Fig. 4.6.1c);
b) it increased greatly in peri-Golgi vesicles/tubules (the number of which also increased 
two- to three-fold; Fig. 4.6.1b, d, e);
c) it started to return back to the cA/medial localisation, which is typical o f the MANI-FM 
monomers (Fig. 4.6.1f, Fig. 4.6.2a-f). Throughout this redistribution process, the total 
levels of MANI-FM did not change detectably in the Golgi ministacks or in the Golgi 
ribbon. Notably, more than 50% of the MANI-FM-containing vesicles and tubules stained 
for COPI (Fig. 4.6.3g). Thus, the depolymerisation of MANI-FM in the /r<ms-cistema 
appears to result in a burst of recycling mediated via COPI-dependent vesicles and tubules,
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and in the rapid redistribution of MANI-FM to the proximal cistemae. Even though the 
amount of overexpressed MANI-FM was only two- to three-fold that of the endogenous 
enzyme (Fig. 4.1.1c), the sudden appearance of all o f the cA/medial resident MANI-FM in 
the trans-cistema can presumably be sensed and compensated for by mechanisms that 
actively respond to variable demands on the recycling process.
I also examined the structure of the Golgi carriers and of the Golgi stack by 
tomography. All o f the reconstructions indicated that the morphology of the carriers (Fig. 
4.6.3a-f) and the structure and size o f the Golgi stack were similar under all experimental 
conditions (Fig. 4.5.1.4c, d). Moreover, tomography confirmed that most round, 50-nm to 
80-nm structures were indeed vesicles (Fig. 4.6.3a-f), and that the relative frequency of 
vesicles and tubules was similar to that seen in thin sections.
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Figure 4.6.1 MANI-FM recycles from the trans- to the as-/medial Golgi after 
depolymerisation in the trans-G olgi
(a, b) HeLa cells were transfected with MANI-FM in the presence of A PI2998, and then 
the A PI2998 was removed for 20 min to induce MANI-FM polymerisation and the 
transfer of MANI-FM to the Pwzs-cistema (a); finally, A PI2998 was added for 1.5 min (b). 
Arrowheads in (b) indicate the peri-Golgi carriers seen after A PI2998 addition, (c, d) The 
lateral distribution of MANI-FM along the cisternal length (c) and the distribution of
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MANI-FM in peri-Golgi carriers (d), expressed as the linear density, (e) The membrane 
length of vesicles and tubules as a measure of the surface area was quantified and is 
expressed as the perimeter (in pm), (f) Co-localisation of COPI and MANI-FM in vesicles 
and tubules (arrowheads) in cells fixed 1.5 min after addition of AP 12998, to depolymerise 
MANI-FM. (g) The change in the distribution of MANI-FM from the trans- to the cis- 
/medial Golgi after addition of API2998 is expressed as the linear density (L.D.) 
normalised to that of the maximum (see Fig. 4.4.1.1 for description). Around 10-20 Golgi 
stack profiles were examined for each time point. Data are means ±SEM. Bars: (a, b) 220 
nm
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Figure 4.6.2 MANI-FM recycling visualised by confocal microscopy.
(a-f) HeLa cells were fixed in the presence of AP 12998 (a, d), after 20 min of API2998 
wash-out (b, e), and 5 min after readdition of AP 12998 (c, f). The cells were then stained 
for MANI-FM (green), GM130 (blue), and TGN46 (red). The white arrows across the 
stacks were used for the line-scan analyses. The fluorescence intensity distribution of 
markers along the line scan (a-c, arrow), normalised to their respective peak values, is 
shown in (d-f). The images are representative of >30 stacks analysed for each condition 
from three independent experiments. For this experiment, n = 30. Bars: (a-c) 1 pm.
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Figure 4.6.3 Round profiles seen in thin sections are actual vesicles and they are 
COPI coated.
(a) HeLa cells expressing MANI-FM were cultured in the presence of A P I2998 and then 
A PI2998 was washed out for 20 min before adding it back again for 1.5 min. The cells 
were then fixed and processed for tomography and cryoimmunogold labelling, (a-f) A 
single frame from the tomographic reconstruction of a Golgi stack (a). The boxed area 
containing round profiles is enlarged in (b-f). Frames are shown from the tomographic 
reconstruction where two round profiles (arrowheads) were followed, to validate them as 
isolated vesicles, (g) The cells were processed as in (a) and then fixed and processed for
1 0 8
cryoimmunogold labelling with anti-P-COP antibodies (15-nm gold) and anti-HA 
antibodies (5-nm gold; MANI-FM). The COPI-coated structures contain MANI-FM 
(arrowheads), (g) Co-localisation of COPI and MANI-FM in vesicles and tubules 
(arrowheads) in cells fixed 1.5 min after addition of AP12998 to depolymerise MANI-FM. 
Bars: (a) 180 nm; (b-f) 60 nm, (g) 120 nm.
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CHAPTER 5.
Discussion
A peculiar characteristic of the eukaryotic cell is the presence of organelles that are 
membrane-bound structures that allow the spatial restriction of specific enzymatic reaction, 
thus improving certain cellular functions. This compartmentalization, at the same time, 
prevents potential damage that dangerous molecules could cause if  they could freely roam 
within the cell. Obviously, cellular organelles need to exchange specific molecules 
between each other and, in other cases, molecules have to be secreted out of the cell. To 
insure the correct delivery of molecules to the right place, eukaryotic cells have developed 
different transport strategies such as compartmental fusion, transport mediated by coated 
vesicles or large pleiomorphic carriers as well as direct tubular continuities between 
distinct compartments (see review by De Matteis and Luini, 2011).
A common factor of all of these transport strategies is represented by three different 
processes that include budding, fission and fusion, a series of events that can promote 
different mechanisms of transport according to their sequence of action.
An important and still unresolved question in cell biology concerns the mechanisms of 
intra-Golgi transport. Two classes of mechanisms have been proposed: one is based on 
stable cistemae that contain resident proteins while cargo-laden carriers move across these 
cistemae, and the other is based on progressing and ‘maturing’ cistemae that carry cargo 
forward while residents are recycled through the stack. Thus a key difference between the 
two concerns the behaviour of Golgi-resident glycosylation enzymes. In this work I have 
engineered Golgi-enzyme constmcts that can be polymerized at will to prevent their 
recycling via Golgi carriers.
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This study reports that: (a) monomeric MANI-FM localises to m/medial Golgi cistemae 
and is present in peri-Golgi vesicles and tubules (Fig. 5.1a); and (b) upon shifting to a 
polymeric state, MANI-FM moves from the rims to the centre o f the cistemae, cannot enter 
peri-Golgi carriers (Fig. 5.1b), and shifts from the cis to the trans-G olgi, while remaining 
within the cistemae (Fig. 5.1c). This movement occurs at the same rate as supramolecular 
secretory cargo that have been proposed to move by cisternal progression (Bonfanti, 
Mironov et al. 1998). Moreover, when MANI-FM is depolymerised in the /nms-cistema, it 
rapidly re-enters the cisternal rims and vesicles/tubules, and shifts back towards its cis- 
Golgi location (Fig. 5.1d). These findings are consistent with the cistemal- 
progression/maturation mechanism, and are inconsistent with stable cistema schemes 
(Rizzo, Parashuraman et al. 2013).
A more detailed analysis is necessary to compare the experimental observations 
made in this study with all o f the intra-Golgi transport models that have been proposed 
over the years. This should mainly focus on two fundamental aspects for a critical and 
comparative analysis: the anterograde movement of cargoes and the mechanisms of 
recycling of Golgi resident enzymes that is predicted by each model.
As noted, cisternal maturation predicts that MANI-FM polymers that cannot enter 
transport carriers will move forward within the advancing cistemae. Instead, stable cistema 
models predict that MANI-FM will be retained within the cistemae irrespective of its 
polymerisation status. Here, it can be hypothesised that polymerisation might somehow 
induce MANI-FM to move across stable cistemae. However, MANI-FM can do so only by 
entering anterograde transport carriers, which is just the opposite o f what is observed 
experimentally: polymerisation induces a nearly complete decrease of MANI-FM in all 
types of peri-Golgi carriers and a shift o f this construct from the rims to the centre o f the 
cistemae, a location that is not suitable for export. Finally, while maturation models require 
efficient and adaptable enzyme recycling mechanisms, stable cistema models do not. A
possible complexity might be that under the stable cistema models the Golgi resident 
enzymes might ‘leak’ forward and be recycled back by carriers. However, this would not 
predict forward transport of the resident enzymes upon polymerisation with kinetics 
similar to the intra-Golgi transport of cargoes.
The rapid-partitioning model suggests that the cis-to-trans movement of cargoes is 
observed only after low-temperature-induced synchronisation, while at physiological 
temperatures both newly arrived and pre-existing cargoes in the Golgi apparatus have an 
equal probability of exiting i.e., the cargo can exit even from the cis-side of the Golgi 
apparatus where an exit domain can be formed due to the non-homogenous lipid 
distribution (Patterson, Hirschberg et al. 2008). Our observations o f the cis-to-trans 
movement of cargoes upon polymerisation directly contradicts this prediction o f the model. 
Finally, the rapid-partitioning model proposes that the polarised distribution of the Golgi 
resident enzymes is due to the affinity of their transmembrane domains for the differential 
lipid distribution across the Golgi apparatus. As we have not studied the lipid affinities of 
MANI-FM during its monomeric or polymeric state, this prediction cannot be tested at the 
moment.
According to the cistemal-progenitor model (see also the kiss-and-run model; 
Mironov and Beznoussenko 2012), the anterograde movement of cargo is the result of 
segregation of Rabs within the Golgi cistemae, which would lead to homotypic fusion o f  
compartments enriched in the same Rabs via the generation of intercistemal connections 
(see model in Fig. 1.4, 3). As an example o f such an intermediate, I have chosen a 
published EM micrograph showing the Golgi apparatus of a guinea pig exocrine pancreas 
cell (Fig 5.2a; Pfeffer 2010; see original Figure in Farquhar and Palade 1981; Fig. 5.2b), 
where a discontinuity in the Golgi cistemae was presented as an example of this process. 
The discontinuous cistemae seen in the transverse section of the Golgi apparatus (Fig. 5.2a, 
b; (Pfeffer 2010; Farquhar and Palade 1981) could be the result of two very different
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situations that can be settled only by observation of tangential sections of the cistemae (see 
cartoon in Fig. 5.2d-f). The presence of two distinct pieces of cistemae that are not 
connected (Fig. 5.2d) or are connected by tubules (Fig. 5.2f), or the presence of a hole 
inside the cistemae (Fig. 5.2e), could generate the discontinuities seen in the cross-section 
of the Golgi apparatus (Fig. 5.2a, b). While this last option is known to exist and is well 
documented, as well as in the Golgi stack (Fig. 5.2c; Ladinsky, Mastronarde et al. 1999; 
Rambourg and Clermont 1990), the former situation (Fig. 5.2f) has never been observed. 
This consideration indicates a weakness in the cistemal-progenitor model. Regarding the 
anterograde movement o f large cargoes through the Golgi apparatus, the progenitor model 
proposes an “alternative homotypic fusion process”, which implies that a homotypic fusion 
event between two neighbouring cistemae from adjacent Golgi stacks promotes the 
forward movement o f cargo. As the experiments reported here were carried out in the 
presence of nocodazole (see Material and Methods; Section 3.8), which separates the Golgi 
ribbon into individual stacks, and thus prevents inter-stack exchange although it still allows 
forwards movement of cargoes, these observations directly contradict the cistemal- 
progenitor model. Although this model does not exclude the possibility that other types of 
Golgi dissociative carriers, like megavesicles, might be involved in anterograde transport 
of "large aggregates", such membranous structures were never observed in my samples; 
nevertheless, it is important to note that the fission and fusion process o f these carriers 
might be very fast events, thus preventing their routine detection.
Along the same lines, considering that the cistemal-progenitor model is based on a 
mechanism of Rab conversion, a segregation of polymeric MANI-FM is also needed for its 
incorporation in megavesicles. At steady-state, MANI-FM appears to be more concentrated 
at the rims than in the central parts of the Golgi cistemae, but upon polymerisation the 
MANI-FM is distributed randomly along the cisternal length, making it difficult to 
reconcile these observations with the predictions of this model.
113
A recent publication from the laboratory of Rothman described the trafficking of a 
modified CD8 transmembrane cargo through the Golgi complex, using the same FM 
strategy that I applied in this study. The experimental approach was the same, and consists 
of the aggregation of a synchronised transmembrane cargo on the cis side of the Golgi 
apparatus to discriminate between static versus mobile Golgi cistemae (see also objective; 
Chapter 2). When modified, the CD8 protein was allowed to polymerise in the ER in a 
trans configuration, where it forms membrane constrictions that was named by Lavieu et al. 
(2013) as “staples”. Through the manipulation of the temperature and the aggregation 
status of the artificial protein, the Rothman team was able to localise the protein to the cis- 
Golgi and then to induce the formation of staples there, and finally to follow the fate o f the 
aggregates. They showed that cargoes remained where they had been ‘stapled’, but without 
stapling, they moved to the cell surface (Lavieu, Zheng et al. 2013). Under conditions in 
which staples were allowed to form in the Golgi apparatus, the transport of VSVG, 
collagen, and a soluble aggregate of growth hormone (hGH), were not affected. These 
observations fit with the idea of a static Golgi compartment, which is opposite to what I 
have found in my study.
The only weakness of the study of Rothman and colleagues is that there were no 
quantifications related to the microscopy observations, so it is hard to say whether the 
phenotype is rare and representative of a subset of Golgi stacks. Lavieu et al. (2013) also 
did not determine the size o f the polymerised CD8; indeed, it is highly possible that the 
polymerisation can induce the formation of aggregates with different sizes, and not all o f  
the polymerised CD8 can form staples. In support of this hypothesis, the EM micrograph 
used by Lavieu et al. (2013) to highlight the staples in the ER (Fig. 5.2g) clearly shows that 
pieces of the ER are completely swollen, which indicates that a massive amount o f protein 
resides in that region. Therefore, it is possible that only a few Golgi stacks have these 
staples, and their presence inside the cistemae might affect the functionality o f these
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ministacks. The observation that different cargoes, including VSVG, can cross the Golgi 
normally under aggregation conditions of CD8 might be the result o f the cargo bypass of 
these inactive Golgi ministacks. Obviously this is speculation, but these possibilities can be 
tested simply by breaking the Golgi ribbon with nocodazole and then applying the same 
polymerisation protocol o f CD8-FM. If this hypothesis is correct, the non-functional Golgi 
ministacks with the staples should not allow the transport of VSVG or other cargo proteins, 
or they might be empty of cargoes. This model proposes the existence o f a stable cisternal 
centre and a "maturing" rim that progresses forwards, thereby transporting large cargoes 
from the cis to the trans side o f the Golgi. Nevertheless, the observations presented in my 
study show that upon polymerisation, MANI-FM shifts from the cisternal rims to a random 
distribution, but nevertheless "progresses" from cis to trans, which suggests that the 
observed progression involves the complete cistemae rather than the rims alone.
Thus, my experimental observations can be only partially explained by the models 
mentioned so far. The simplest interpretation of the data reported in this study is that 
monomeric MANI-FM normally recycles backwards in the stack in step with the 
progression of the cistemae (and of the cargoes) via retrograde transport intermediates, to 
maintain its cis location, and that when its recycling is inhibited by polymerisation it 
progresses through the stack along with the cisternal flow. The findings in my study are 
therefore consistent with the cistemal-progression/maturation mechanism, and not with 
stable cistemae models.
A further line of evidence in favour of cisternal maturation is that when MANI-FM 
is depolymerised in the /raws-cistema, it rapidly re-enters the cisternal rims as well as 
vesicles/tubules and shifts back toward its c/s-Golgi location. These data represent 
evidence for the rapid recycling of Golgi resident enzymes through the stack in mammals. 
Notably, a Golgi enzyme, GAlNacT2, has been reported recently to cycle rapidly between 
the Golgi apparatus and the intermediate compartment in mammals (Jarvela and Linstedt
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2012). This finding does not relate to the progression/maturation of the cistemae through 
the stack; rather it reflects the formation of new cw-cistemae from the intermediate 
compartment (Jarvela and Linstedt 2012).
Regarding the mechanism of recycling, the MANI-FM-containing carriers that 
proliferate upon MANI-FM depolymerisation appear to be COP-I-coated tubules and 
vesicles. Discordant conclusions have been proposed in the past regarding the question of 
whether vesicles or tubules (which might be dissociated or connected with adjacent 
cistemae) are involved in recycling (Orci, Amherdt et al. 2000; Lanoix, Ouwendijk et al. 
2001; Martinez-Menarguez, Prekeris et al. 2001; Kweon, Beznoussenko et al. 2004; 
Tmcco, Polishchuk et al. 2004). The data from my study, and the recent proposal that 
Golgi vesicles and tubules are strongly mechanistically related (Yang, Valente et al. 2011), 
might explain the previous discrepancies.
These findings do not show that cisternal maturation is the only mode of intra- 
Golgi transport; indeed, these transport mechanisms are not mutually exclusive (Emr, 
Glick et al. 2009). Thus, although my data provide evidence for cisternal maturation, they 
do not exclude that other transport principles might coexist with the maturation process in 
the Golgi complex, such as vesicular trafficking (Rothman and Wieland 1996; Malsam, 
Satoh et al. 2005) or diffusional trafficking via continuities (Tmcco, Polishchuk et al. 
2004). Here, the prevailing mechanism perhaps depends on the type o f cargo being 
transported, the pathophysiological conditions, the cell type, and/or the trafficking step 
being examined. Examples of the eclectic nature of the transport apparatus have been 
provided by studies o f the endocytic pathway, where different transport principles have 
been shown to coexist (Pryor and Luzio 2009; De Matteis and Luini 2011). Membrane 
trafficking has central roles in many cellular processes (Mellman and Warren 2000; De 
Matteis and Luini 2011), thus a better understanding o f the full repertoire o f eukaryotic
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trafficking principles will provide valuable insights into key aspects o f cell physiology and 
pathology.
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Fig. 5.1 Working model.
(a-d) The dynamics of a czs-Golgi resident enzyme support the cistemal-maturation model, 
(a) Steady-state distribution of MANI-FM. (b) After polymerisation, MANI-FM disappears 
from vesicles/ tubules and appears randomly distributed in the cistemae. (c) The MANI- 
FM polymer can shift from the c/s-medial to the trans Golgi stack, (d) Depolymerisation of 
MANI-FM in the trans-G olgi induces its fast re-distribution into the cisternal rims and 
vesicles/ tubules, and shifts it back towards its czs-Golgi location.
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(a, b) Electron micrographs o f the Golgi apparatus of a guinea-pig exocrine pancreas cell 
(Farquhar and Palade 1981; Pfeffer 2010). (a) Adapted electron micrograph of b, chosen 
by (Pfeffer 2010) to emphasise the discontinuity of the cistemae, to describe the progenitor 
model, (b) Original electron micrograph o f the Golgi (Farquhar and Palade 1981). (c) 
Stereo images of three Golgi cistemae (from C3 to C5) showing wells (image from 
Ladinsky, Mastronarde et al. 1999). (d) Schematic representation of a discontinuous Golgi 
cistema in transverse section, (e) Schematic representation of a Golgi cistema with a well, 
in tangential section, (f) Schematic representation of a Golgi cistema composed o f two 
pieces connected to each other by a tubule, in tangential section, (g) Adapted electron 
micrograph from (Lavieu, Zheng et al. 2013) showing CD8 staples in the ER (red box) of 
HeLa cells. Red arrowheads, pieces of swollen ER.
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